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A B S T R A C T
Background
Surgical removal of the tonsils, with or without adenoidectomy (adeno-/tonsillectomy), is a commonENToperation, but the indications
for surgery are controversial. This is an update of a Cochrane review first published in The Cochrane Library in Issue 3, 1999 and
previously updated in 2009.
Objectives
To assess the effectiveness of tonsillectomy (with and without adenoidectomy) in children and adults with chronic/recurrent acute
tonsillitis in reducing the number and severity of episodes of tonsillitis or sore throat.
Search methods
We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials
(CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; Cambridge Scientific Abstracts; ISRCTN and additional sources for
published and unpublished trials. The date of the most recent search was 30 June 2014.
Selection criteria
Randomised controlled trials comparing tonsillectomy (with or without adenoidectomy) with non-surgical treatment in adults and
children with chronic/recurrent acute tonsillitis.
Data collection and analysis
We used the standard methodological procedures expected by The Cochrane Collaboration.
Main results
This review includes seven trials with low to moderate risk of bias: five undertaken in children (987 participants) and two in adults
(156 participants). An eighth trial in adults (40 participants) was at high risk of bias and did not provide any data for analysis. Good
information about the effectiveness of adeno-/tonsillectomy is only available for the first year following surgery in children and for a
shorter period (five to six months) in adults.
1Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
We combined data from five trials in children; these trials included children who were ’severely affected’ (based on the specific ’Paradise’
criteria) and less severely affected. Children who had an adeno-/tonsillectomy had an average of three episodes of sore throats (of any
severity) in the first postoperative year, compared to 3.6 episodes in the control group; a difference of 0.6 episodes (95% confidence
interval (CI) -1 to -0.1; moderate quality evidence). One of the three episodes in the surgical group was the ’predictable’ one that
occurred in the immediate postoperative period.
When we analysed only episodes of moderate/severe sore throat, children who had been more severely affected and had adeno-/
tonsillectomy had on average 1.1 episodes of sore throat in the first postoperative year, compared with 1.2 episodes in the control group
(low quality evidence). This is not a significant difference but one episode in the surgical group was that occurring immediately after
surgery.
Less severely affected children had more episodes of moderate/severe sore throat after surgery (1.2 episodes) than in the control group
(0.4 episodes: difference 0.8, 95% CI 0.7 to 0.9), but again one episode was the predictable postoperative episode (moderate quality
evidence).
Data on the number of sore throat days is only available for moderately affected children and is consistent with the data on episodes.
In the first year after surgery children undergoing surgery had an average of 18 days of sore throat (of which some - between five and
seven on average - will be in the immediate postoperative period), compared with 23 days in the control group (difference 5.1 days,
95% CI 2.2 to 8.1; moderate quality evidence).
When we pooled the data from two studies in adults (156 participants), there were 3.6 fewer episodes (95% CI 7.9 fewer to 0.70 more;
low quality evidence) in the group receiving surgery within six months post-surgery. However, statistical heterogeneity was significant.
The pooled mean difference for number of days with sore throat in a follow-up period of about six months was 10.6 days fewer in
favour of the group receiving surgery (95% CI 5.8 fewer to 15.8 fewer; low quality evidence). However, there was also significant
statistical heterogeneity in this analysis and the number of days with postoperative pain (which appeared to be on average 13 to 17
days in the two trials) was not included. Given the short duration of follow-up and the differences between studies, we considered the
evidence for adults to be of low quality.
Two studies in children reported that there was “no statistically significant difference” in quality of life outcomes, but the data could
not be pooled. One study reported no difference in analgesics consumption. We found no evidence for prescription of antibiotics.
Limited data are available from the included studies to quantify the important risks of primary and secondary haemorrhage.
Authors’ conclusions
Adeno-/tonsillectomy leads to a reduction in the number of episodes of sore throat and days with sore throat in children in the first
year after surgery compared to (initial) non-surgical treatment. Children who were more severely affected were more likely to benefit
as they had a small reduction in moderate/severe sore throat episodes. The size of the effect is very modest, but there may be a benefit
to knowing the precise timing of one episode of pain lasting several days - it occurs immediately after surgery as a direct consequence
of the procedure. It is clear that some children get better without any surgery, and that whilst removing the tonsils will always prevent
’tonsillitis’, the impact of the procedure on ’sore throats’ due to pharyngitis is much less predictable.
Insufficient information is available on the effectiveness of adeno-/tonsillectomy versus non-surgical treatment in adults to draw a firm
conclusion.
The impact of surgery, as demonstrated in the included studies, is modest. Many participants in the non-surgical group improve
spontaneously (although some people randomised to this group do in fact undergo surgery). The potential ’benefit’ of surgery must be
weighed against the risks of the procedure as adeno-/tonsillectomy is associated with a small but significant degree of morbidity in the
form of primary and secondary haemorrhage and, even with good analgesia, is particularly uncomfortable for adults.
P L A I N L A N G U A G E S U M M A R Y
Surgical removal of the tonsils (tonsillectomy) for chronic or recurrent acute tonsillitis
Review question
This review compared the clinical effectiveness and safety of surgery (removal of the tonsils - tonsillectomy, or adenotonsillectomy -
removal of the tonsils and adenoid tissues) against non-surgical management in adults and children with frequent or chronic tonsillitis.
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Background
Surgical removal of the tonsils is a commonly performed operation in patients with chronic or recurrent infections of the tonsils
(tonsillitis) or the other tissues at the back of the throat (pharyngitis). Sometimes, the adenoid tissues are also removed during the
surgery. However, opinions vary greatly about whether or not the benefits of these operations outweigh the risks.
Study characteristics
This review included evidence available up to 30 June 2014. Seven trials with low to moderate risk of bias were included: five in children
(987 participants) and two in adults (156 participants). An eighth trial in 40 adults was at high risk of bias and did not provide any
data for analysis.
Although some studies in children followed participants for two or three years, reliable information is only available for up to about
one year after surgery due to the high number of participants missing follow-up after the first year. Some studies had recruited children
who were more severely affected by tonsillitis than other studies (for example, they had tonsillitis more often and with more severe
symptoms). Therefore, we grouped the children into ’severely affected’ and ’less severely affected’ subgroups.
Two studies in adults had a short duration of follow-up (five to six months following surgery).
Key results
We found that in general children affected by recurrent acute tonsillitis may have a small benefit from adeno-/tonsillectomy: this
procedure will avoid 0.6 episodes of any type of sore throat in the first year after surgery compared to non-surgical treatment. The
children who had surgery had three episodes of sore throat on average compared to 3.6 episodes experienced by the other children.
One of the three episodes is the episode of pain caused by surgery.
When it comes to avoiding bad sore throats, children who have more severe or frequent tonsillitis may benefit more from surgery
compared to less severely affected children. In less severely affected children the potential benefits of adeno-/tonsillectomy are more
uncertain. There are no good quality data for the effects of surgery in the second or later years after surgery.
We did not find enough evidence to draw firm conclusions on the effectiveness of tonsillectomy in adults with chronic/recurrent acute
tonsillitis. Evidence is only available for the short term and is of low quality. The data are also difficult to interpret as the studies do
not take into account the days of pain that always follow the operation. Based on the two small trials, tonsillectomy seems to result in
fewer days of sore throat in the first six months after surgery.
Two of the studies in children said that they could not find a difference in quality of life outcomes and one study could not find a
difference in the amount of painkiller that children took to help with their sore throats.
Bleeding immediately after tonsillectomy or in the two weeks following surgery is an important complication. The studies did not
provide good information to allow us to assess accurately the risk of these complications.
Quality of the evidence
We judged the quality of the evidence to be moderate for the data on children (this means that further research is likely to have an
important impact on how confident we are in the results and may change those results). Quality is affected by a large number of children
who are ’lost to follow-up’ after the first year of the study. In addition, some children who are assigned to the ’no surgery’ group end
up having surgery.
The quality of evidence for tonsillectomy in adults in adults is low.
As always, any potential benefits of surgery should be carefully weighed against the possible harms as the procedure is associated with a
small but significant degree of morbidity in the form of bleeding (either during or after the surgery). In addition, even with good pain
relief medication, the surgery is particularly uncomfortable for adults.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Tonsillectomy or adenotonsillectomy versus no surgery in children with chronic/ recurrent acute tonsillitis
Patient or population: Children with chronic/ recurrent acute tonsillit is
Settings: Patients recruited f rom primary care or specialist centres
Intervention: Tonsillectomy or adenotonsillectomy versus no surgery
Outcomes Illustrative comparative risks* (95% CI) No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Tonsillectomy or adeno-
tonsillectomy
Episodes of sore throat of
any severity
Including as 1 episode the
period post-surgery)
Follow-up: median 1 year
Ranged f rom 2.9 to 7.7
episodes (median = 3.3,
weighted mean = 3.6)1
0.6 fewer episodes
(1.0 to 0.1 lower)
795
(5 studies)
⊕⊕⊕©
moderate2,3
The SMD was -0.7 (95% CI
-0.9 to -0.5). As a rule of
thumb, 0.2 SMD represents
small, 0.5 moderate and 0.
8 a large ef fect
Data f rom severely and
moderately af fected pat ient
subgroups are not shown
separately as the results
were pooled
Episodes of moderate/ se-
vere sore throat (subgroup of
severely affected patients)
Including as 1 episode the
period post-surgery)
Follow-up: median 1 year
Mean = 1.2 episodes 0.1 fewer episodes
(0.6 fewer to 0.4 more)
73
(1 study)
⊕⊕©©
low3,4,5
Data f rom severely and
moderately af fected pa-
t ients were not pooled.
Tests for subgroup dif fer-
ences were stat ist ically sig-
nif icant
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Episodes of moderate/ se-
vere sore throat (subgroup of
moderately affected patients)
Not including as 1 episode
the period post-surgery
Follow-up: median 1 year
Ranged f rom 0.2 to 0.
9 episodes (median = 0.4
episodes, weighted mean =
0.4 episodes)
0.8 more episodes
(0.7 to 0.9 more)
491
(3 studies)
⊕⊕⊕©
moderate2,3
Sore throat days (includ-
ing those immediately post-
surgery
Follow-up: median 1 year
Ranged f rom 18.9 to 49.1
days (median = 24.0 days,
mean = 23.2 days)
5.1 fewer days
(8.1 to 2.2 fewer)
776
(5 studies)
⊕⊕⊕©
moderate2,3
Absence from school or
work (standardised to 180
school days or followed up
for 5 to 6 months)
Ranged f rom
5.3 to 6.6 days (median =
6.3 days, weighted mean =
5.9 days)
2.3 fewer days
(3.4 to 1.2 fewer)
412
(4 studies)
⊕⊕⊕©
moderate5
Complications - results not
pooled
Studies reported a number of dif f erent complicat ions - not predef ined and unclear
def init ions. See Table 1 for more details
⊕⊕©©
low6
All- cause mortality - not re-
ported
None of the studies reported death as an outcome or complicat ion ⊕⊕©©
low6
Quality of life - results not
pooled
Insuf f icient information to pool results. 2 studies (using dif ferent scales) reported no
dif ference
⊕⊕©©
low6
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; SD: standard deviat ion; SMD: standardised mean dif ference
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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1Where there were more than three studies, the control group risk shown is the range, median and the weighted mean of the
pooled analysis of the control groups of all included studies. The mean shown is the weighted mean of the control groups
of all included studies. The assumed risk was calculated f rom the weighted mean f rom the meta-analysis.
2Borderline decision. All studies were unblinded studies and methods of measurement were not standardised or clearly
def ined in the studies. One study collected data f rom patient diaries, but only about 50% of diaries were returned and the data
were averages f rom the returned diaries (Lock 2010). This could be an overest imation of the number of episodes and days
with sore throat.
3Data were only pooled f rom studies in children.
4Small sample size. Study only reported outcomes for 38 out of 43 and 35 out of 48 pat ients recruited in the treatment and
control group, respect ively, and the proport ion of pat ients not included in the analysis is higher in the control group.
5There were stat ist ically signif icant subgroup dif ferences between the moderately af fected versus the severely af fected
groups. Results were not pooled for this outcome.
6 Results were not clearly reported and could not be analysed. Sample size may be too small to measure reliably mortality
and rarer complicat ions.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
This is an update of a Cochrane review first published in The
Cochrane Library in Issue 3, 1999 (Burton 1999) and previously
updated in 2009 (Burton 2009).
Sore throat is a common reason for consultation with a doctor
in primary care (Ashworth 2004). The symptoms may be caused
by infection of the pharynx in general or the tonsils in particular,
in which case the terms pharyngitis and tonsillitis may be used
respectively. It may be difficult, or impossible, to distinguish ac-
curately between the two conditions, although when the tonsils
are red and swollen a diagnosis of tonsillitis is more likely to be
made. Doctors disagree on the clinical features that might allow a
distinction to be made between tonsillitis and pharyngitis or sore
throat.
Although self limiting in the vast majority of patients, the symp-
toms are inconvenient. As a consequence, antibiotics are frequently
prescribed for this condition in general practice (Ashworth 2004).
While many patients experience only occasional throat infections
with a relatively short duration of illness, a subset of patients suf-
fer from chronic/recurring acute episodes, which causes a consid-
erable disease burden through frequent episodes of sore throat,
fever, general illness, sleepless nights, impaired daily functioning
and absence from school or work.
Description of the intervention
Surgical removal of the tonsils (tonsillectomy) is one of the most
common surgical procedures performed in children (Paradise
1996). Tonsillectomy is performed under general anaesthesia and
involves surgical removal of the palatine tonsils from their invest-
ing tissues. The risks of surgery include those of the associated
general anaesthetic and those specific to the procedure, for exam-
ple bleeding immediately after surgery or as a result of secondary
infection in the 10- to 14-day period after surgery. When the ade-
noids are also removed, this is called adenotonsillectomy.
How the intervention might work
If a patient has no tonsils, they cannot get tonsillitis. However, they
may still suffer from pharyngitis and sore throats. Whilst the pala-
tine tonsils are considered to play an important role in the causa-
tion of chronic/recurrent acute throat infections, they are probably
not the only factor responsible. As a consequence, tonsillectomy
may prevent further throat infections and/or reduce the severity of
future throat infections and could therefore considerably improve
patients’ daily functioning and health-related quality of life. It is
unclear whether the removal of adenoids has additional benefits
or harms compared to tonsillectomy alone.
Why it is important to do this review
The indications for tonsillectomy (with or without adenoidec-
tomy) are controversial. It is generally accepted that tonsillectomy
(with adenoidectomy, if necessary) is indicated in children with
obstructive sleep apnoea. The role of the procedure in other types
of sleep-disordered breathing is the subject of research and debate
(Blackshaw 2014; Venekamp 2014). Although tonsillectomy is
also frequently performed in patients who have chronic tonsillitis,
recurrent acute tonsillitis or recurrent pharyngitis/’sore throats’,
opinions vary greatly as to whether or not the benefits outweigh
the risks for this indication. We have mentioned the uncertainty
surrounding the role of the tonsils (and therefore the effect of
their removal) in people with recurrent episodes of tonsillitis/’sore
throat’. An additional concern is that a past pattern of behaviour
maynot continue.Many patientswith recurrent symptoms are said
to ’grow out’ of the problem. A proportion of patients with seri-
ous, recurrent symptoms now, will be symptom-free in 12months’
time. It has not been possible to identify specific risk factors that
would allow those patients to be identified.
A non-systematic review of tonsillectomy or adenotonsillectomy
for recurrent throat infection was published in 1998 (Marshall
1998). This review drew conclusions from trials which either did
not fulfil the inclusion criteria for the present systematic review or
which appeared to contain significant risk of bias. In the previous
version of the current review (Burton 2009), we found four trials
undertaken in children (719 participants) and one in adults (70
participants). Good information about the effectiveness of ton-
sillectomy was only available for (a) children and not adults, and
(b) for the effects of surgery in the first year of treatment, not the
second year or beyond. At that time we found one ongoing trial
on the effectiveness of adeno-/tonsillectomy compared to non-
surgical management in children aged 4 to 15 years with recurrent
sore throats (the North of England and Scotland Study of Ton-
sillectomy and Adenotonsillectomy in Children - NESSTAC). In
the current update of our review, we included data from this trial
(Lock 2010), and one other (Koskenkorva 2013).
O B J E C T I V E S
To assess the effectiveness of tonsillectomy (with and without ade-
noidectomy) in children and adults with chronic/recurrent acute
tonsillitis in reducing the number and severity of episodes of ton-
sillitis or sore throat.
As secondary objectiveswe sought to address the following research
questions. In children and adults with chronic/recurrent acute
tonsillitis:
• What is the effectiveness of tonsillectomy alone?
• What is the effectiveness of adenotonsillectomy?
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• Is there a difference in the effectiveness of tonsillectomy
versus adenotonsillectomy?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs), with no restrictions on pub-
lication status or language of publication.
Types of participants
We included children and adults diagnosed by general practition-
ers or ear, nose and throat (ENT) specialists as having either ’recur-
rent acute tonsillitis’ or ’chronic tonsillitis’ and considered them
separately.
No microbiological diagnosis was required; we deemed a clinical
diagnosis of tonsillitis satisfactory. We considered recurrent acute
tonsillitis to be more than two distinct episodes in a 12-month
period, and chronic tonsillitis as symptoms of tonsillitis for a period
longer than three months.
Types of interventions
Intervention
Surgical treatment in the form of tonsillectomy, with or without
adenoidectomy, by any surgical method (dissection, guillotine,
electrocautery, laser, coblation or any other).
Comparator
Non-surgical treatments such as:
1. no treatment (including watchful waiting) with or without
analgesics (pain relief ) only;
2. repeated short courses of antibiotics; and
3. long-term antibiotics.
We anticipated that some studies may use ’watchful waiting’ as
the initial management strategy in the non-surgical comparator
group, but that some participants allocated to this group may
undergo surgery before the end of the study (i.e. cross over into
the ’treatment’ arm).
Types of outcome measures
We selected three primary outcomes (one of which related to ad-
verse effects of surgery).
Primary outcomes
• Number and severity of episodes of tonsillitis or sore throat
• Number of days with sore throat
• Morbidity and mortality of surgery (measures of morbidity
include complications of surgery and number of days with
postoperative pain)
Secondary outcomes
• Consumption of antibiotics
• Consumption of analgesics
• Absence or time off work or school
• Quality of life
We sought data on the assessment of outcomes at three months,
six months and 12 months, and in the second and subsequent
years after randomisation.
In the 2014 update, we added quality of life as an outcome not
only because of the availability of data in two included studies,
but also to acknowledge the importance of this outcome.
Search methods for identification of studies
We conducted systematic searches for RCTs. We placed no restric-
tions on language, publication year or publication status. The date
of the last search was 30 June 2014, following previous update
searches and original searches in 1999.
Electronic searches
We searched the following databases from their inception for pub-
lished, unpublished and ongoing trials: the Cochrane Ear, Nose
and Throat Disorders Group Trials Register; the Cochrane Cen-
tral Register of Controlled Trials (CENTRAL 2014, Issue 6);
PubMed; EMBASE; CINAHL; LILACS; KoreaMed; IndMed;
PakMediNet; CAB Abstracts; Web of Science; ISRCTN; Clinical-
Trials.gov; ICTRP; Google and Google Scholar. In searches prior
to 2013, we also searched BIOSIS Previews 1926 to 2012.
We modelled subject strategies for databases on the search strat-
egy designed for CENTRAL. Where appropriate, we combined
subject strategies with adaptations of the highly sensitive search
strategy designed by The Cochrane Collaboration for identifying
randomised controlled trials and controlled clinical trials (as de-
scribed in theCochrane Handbook for Systematic Reviews of Inter-
ventions Version 5.1.0, Box 6.4.b. (Handbook 2011)). We revised
the subject search strategies for the 2014 update of this review.
The new search strategies for the major databases are provided in
Appendix 1 and have been used in all subsequent update searches.
The previous version of the search strategy is provided inAppendix
2.
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Searching other resources
We scanned the reference lists of identified publications for addi-
tional trials and contacted trial authors where necessary. In addi-
tion, we searched PubMed, TRIP database and Google to retrieve
existing systematic reviews relevant to this systematic review, so
that we could scan their reference lists for additional trials. We
searched for conference abstracts using the Cochrane Ear, Nose
and Throat Disorders Group Trials Register.
Data collection and analysis
Selection of studies
At least two review authors independently screened titles and ab-
stracts obtained from the database searches at different stages of
the original review and subsequent updates. Similarly, at least two
of the three review authors independently reviewed the full text
of the potentially relevant titles and abstracts against the inclusion
and exclusion criteria. We resolved differences by discussion.
Data extraction and management
At least two of the three review authors independently extracted
data from the included studies using standardised forms. We re-
solved disagreements by discussion.
We also noted possible variations in the definition of outcomes be-
tween studies, and where possible, standardised these across stud-
ies before meta-analysis. See Included studies and Appendix 3 for
more details.
Assessment of risk of bias in included studies
At least two review authors independently assessed the method-
ological quality of the included trials. We resolved any disagree-
ments by discussion. We took the following taken into consider-
ation, as guided by theCochrane Handbook for Systematic Reviews
of Interventions (Handbook 2011):
• sequence generation;
• allocation concealment;
• blinding;
• selective outcome reporting;
• incomplete outcome data;
• other sources of bias.
We used the Cochrane ’Risk of bias’ tool in Review Manager 5
(RevMan 2014), which involves describing each of these domains
as reported in the trial and then assigning a judgement about the
adequacy of each entry: ’low’, ’high’ or ’unclear’ risk of bias.
Results of the ’Risk of bias’ assessment are presented in a ’Risk of
bias’ summary and a ’Risk of bias’ graph.
Measures of treatment effect
We analysed data according to the intention-to-treat principle,
whereby all participants are analysed in the groups to which they
were randomised. Where data were missing or there was loss to
follow-up, we conducted an available case analysis.
We expressed the pooled measures of treatment effect for number
and severity of episodes of tonsillitis or sore throat and number
of days with sore throat as mean differences with 95% confidence
intervals (CIs).
Unit of analysis issues
We identified no studies with non-standard designs, such as cross-
over and cluster-randomised trials.
Dealing with missing data
We planned to seek key unpublished information missing from
reports of included studies, if necessary, by contacting the authors
of the included trials. No imputations for missing data were pre-
planned, apart from standard calculations to obtain SD values for
continuous data as detailed in the Cochrane Handbook for System-
atic Reviews of Interventions (Handbook 2011).
Assessment of heterogeneity
We assessed clinical heterogeneity (which may be present even in
the absence of statistical heterogeneity). We reviewed the included
trials for potential differences between studies in terms of the types
of participants recruited, interventions or control used and how
outcomes were measured and/or reported.
We assessed statistical heterogeneity by visual inspection of the for-
est plots and statistical tests for heterogeneity. We assessed hetero-
geneity using the Chi2 test (with a significance level set at P value
< 0.10) and the I2 statistic, which calculates the percentage of vari-
ability which is due to heterogeneity rather than chance, with I2
values over 50% suggesting substantial heterogeneity (Handbook
2011).
Where there was heterogeneity and a sufficient number of studies
was present, we conducted sensitivity analyses based on risk of bias
and carried out pre-specified subgroup analyses. Assessments of
potential differences in effect sizes between subgroups were based
on the Chi2 tests for heterogeneity statistics between subgroups.
We used a fixed-effect meta-analysis where no heterogeneity was
present. If no sensitivity analysis completely resolved statistical
heterogeneity then we employed a random-effects (DerSimonian
and Laird) model to provide a more conservative estimate of the
effect.
Assessment of reporting biases
We planned to compare the outcomes reported in the trial against
the protocol for the studies whenever possible to assess for re-
porting bias. If a sufficient number of studies had been available,
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we would have conducted more formal assessments using funnel
plots.
Data synthesis
We examined the characteristics of participants, interventions and
comparisons and compared them between studies. If variations in
the intervention or comparator had been found, we would have
investigated these via subgroup analysis or even as different com-
parisons (i.e. not pooled if these were sufficiently different).
We combined the results of individual studies in a meta-analy-
sis where we judged participants, interventions, comparisons and
outcomes to be sufficiently similar, to ensure that an answer would
be clinically meaningful. We calculated treatment differences with
the Mantel-Haenszel method using a fixed-effect or random-ef-
fects model determined by the presence or otherwise of significant
heterogeneity.
For dichotomous data, we analysed treatment differences as risk
ratio (RR) with 95% confidence interval (CI) calculated by the
Mantel-Haenszel method using a fixed-effect model. For contin-
uous data we analysed mean differences (MD) with 95% CIs.
We planned to assume that baseline risk is typically either (a)
the median of the risks of the control groups in the included
studies, this being used to represent a ’medium-risk population’
or, alternatively, (b) the average risk of the control groups in the
included studies is used as the ’study population’ (Handbook
2011). Should further studies be added in future updates it may
also be appropriate to consider assumed baseline risk in (c) a low-
risk population, and (d) a high-risk population.
Subgroup analysis and investigation of heterogeneity
We planned to analyse data for adults and children separately.
We planned to consider the following subgroup analysis, if suffi-
cient data were available:
• Children who were deemed to be ’severely affected’ based
on a specific set of criteria often referred to as the ’Paradise
criteria’ versus less severely affected children with recurrent acute
tonsillitis.
Sensitivity analysis
When this review was first undertaken, there was no evidence to
suggest that variations in surgical treatment (in the form of tonsil-
lectomywith or without adenoidectomy) or in the specific surgical
method (dissection, guillotine, electrocautery, laser, coblation or
any other) were factors affecting the outcomes.
In one of the studies the outcomes of the tonsillectomy alone and
adenotonsillectomy groups were compared (Paradise 1984). Find-
ing no “large or statistically significant” differences between them,
the data sets were pooled and reported as a single ’surgical’ group.
It is, however, not clear whether the sizes of the two original sub-
groups were large enough to detect any true difference between the
effects of tonsillectomy alone and adenotonsillectomy. Some part
of the effect of ’surgery’ could be due to removal of the adenoids.
Therefore we planned to address these assumptions by sensitivity
analysis if data were available. In further sensitivity analysis, we
planned to assess the impact of studies with high risk of attrition
bias on the outcomes
GRADE and ’Summary of findings’
We used the GRADE approach to rate the overall quality of evi-
dence for each outcome. The quality of evidence reflects the extent
to which we are confident that an estimate of effect is correct and
we applied this in the interpretation of results. There are four pos-
sible ratings: high, moderate, low and very low. A rating of high
quality of evidence implies that we are confident in our estimate
of effect and that further research is very unlikely to change our
confidence in the estimate of effect. A rating of very low quality
implies that any estimate of effect obtained is very uncertain.
TheGRADE approach rates evidence fromRCTs that do not have
serious limitations as high quality. However, several factors can
lead to the downgrading of the evidence to moderate, low or very
low. The degree of downgrading is determined by the seriousness
of the these factors:
• study limitations (risk of bias);
• inconsistency;
• Indirectness of evidence;
• imprecision; and
• publication bias.
We included a ’Summary of findings’ table (Summary of findings
for the main comparison), constructed according to the recom-
mendations described in Chapter 10 of the Cochrane Handbook
for Systematic Reviews of Interventions (Handbook 2011). We used
the GRADE considerations to assess the quality of the body of ev-
idence for each primary outcome, and to draw conclusions about
the quality of evidence in the review.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
This is an update of a Cochrane review first published in 1999,
Burton 1999, which was previously updated in 2009 (Burton
2009).
With the updated searches (to 30 June 2014) we retrieved a total of
3285 additional records. Removing duplicates left 1568 records.
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After screening titles and abstracts, we identified five additional
potentially relevant studies (Clayburgh 2011; Koskenkorva 2013;
Lock 2010; Naibo lu 2010; Stalfors 2012). We excluded three
as they were non-randomised cohort studies (Clayburgh 2011;
Naibo lu 2010; Stalfors 2012), leaving two additional trials for
consideration (Koskenkorva 2013; Lock 2010). In addition, we
decided to include a study that had not previously been included
(Stafford 1986); although this study had not reported any data that
could be used for meta-analysis and the randomisation method
was unclear, it did meet the inclusion criteria from our protocol.
Searches in April 2008 retrieved 2746 references, of which we
considered nine studies to be possibly relevant.We excluded one as
it was a non-randomised cohort study (Kaiser 1930), leaving eight
trials for consideration (Alho 2007; Mawson 1967; McKee 1963;
Paradise 1984; Paradise 2002a; Paradise 2002b; Roydhouse 1970;
van Staaij 2004). The two Paradise 2002 studies are reported in
the same paper, but in such a manner that they can be considered
as two separate studies (see further details below) (Paradise 2002a;
Paradise 2002b).
Of 10 potentially relevant trials, three were excluded in 1999 be-
cause it was not clear whether the included children had suffered
from recurrent acute or chronic tonsillitis, as trial entry criteria
were poorly defined (Mawson 1967; McKee 1963; Roydhouse
1970). For example, it was possible to be included in the Maw-
son study by experiencing cervical adenitis (inflamed glands in the
neck) alone (Mawson 1967). This left seven RCTs that satisfied all
our inclusion criteria (Alho 2007; Koskenkorva 2013; Lock 2010;
Paradise 1984; Paradise 2002a; Paradise 2002b; van Staaij 2004).
We identified no additional trials after scanning the reference lists
of the included studies and relevant systematic reviews. We iden-
tified an additional trial, published in 1986, through correspon-
dence with other experts in the field (Stafford 1986), and we have
identified one ongoing trial in adults (NATTINA 2014).
Figure 1 shows a flow chart of the number of studies found in the
search and included or excluded in the review process.
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Figure 1. Process for sifting search results and selecting studies for inclusion
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Included studies
Details of the methods, participants, interventions and outcomes
of the included studies are shown in the table of Characteristics of
included studies.
Design
We included a total of eight unblinded randomised controlled
trials, randomising 987 children and 196 adults, in the review.
Participants and settings
Children
Five of the studies included only children (Lock 2010; Paradise
1984; Paradise 2002a; Paradise 2002b; van Staaij 2004). Four were
published after 2000; one study was conducted between 1971 and
1982 (Paradise 1984).
The severity of symptoms required to enter the trials differed sig-
nificantly. The participants in Paradise 1984 were only eligible if
they were severely affected by tonsillitis; their episodes of throat
infection met strict, pre-defined standards in each of four cate-
gories: (1) frequency of occurrence (seven or more episodes in the
preceding year, or five or more in each of the preceding two years,
or three or more in each of the preceding three years); (2) clinical
features (each episode had to be characterised by specific clinical
features); (3) treatment (they had to have been treated with antibi-
otics when streptococcal infection was proven or suspected); and
(4) documentation (each episode had to have been be documented
in a clinical record). Meanwhile, the other four studies were less
strict in their criteria for severity or frequency of tonsillitis and in-
cluded moderately affected children (Lock 2010; Paradise 2002a;
Paradise 2002b; van Staaij 2004). The van Staaij 2004 trial specif-
ically excluded the type of severely affected child included in the
Paradise 1984 study and their participants were likely to be more
similar to the children included in the Paradise 2002a; Paradise
2002b trials. In addition, the Lock 2010 trial also included chil-
dren with less strict criteria regarding the number and reporting
of recurrent sore throats before trial entry (four or more episodes
of sore throat within each of two years or six or more episodes of
sore throat within one year).
All the ’Paradise’ studies, which were conducted in the United
States, included children aged 3 to 15 (Paradise 1984; Paradise
2002a; Paradise 2002b). Randomisation was stratified into three
age groups. Lock 2010was conducted in theUKand included chil-
dren aged 4 to 15. van Staaij 2004 was conducted in the Nether-
lands and included a younger age group (three to eight years old).
All these studies were funded by the relevant national health re-
search or insurance bodies of the respective countries.
Adults
Three studies conducted in adults met the review inclusion criteria
(Alho 2007; Koskenkorva 2013; Stafford 1986), but only two
of these reported outcomes selected for this review (Alho 2007;
Koskenkorva 2013). Both of these were conducted in the Oulu
region of Finland and no external source of funding or competing
interests were declared.
Alho 2007 recruited participants aged 15 years and above between
2001 and 2005, with proven group A streptococcal pharyngitis.
Participants had tohave documented recurrent episodes of pharyn-
gitis due to group A Streptococcus (three or more episodes in six
months or four episodes in 12 months); the symptoms and signs
had to be “typical of streptococcal pharyngitis” and severe enough
for the patient to seek medical attention. At least one episode had
to be microbiologically proven by culture or rapid antigen test.
Koskenkorva 2013 was conducted between 2007 and 2010. This
study included patients aged 13 and above who were referred
for tonsillectomy because of recurrent pharyngitis (three or more
episodes in the previous 12 months).
However, participants from both studies had a similar number
of episodes of acute pharyngitis diagnosed by a physician before
enrolment (a mean of 3 and 3.5 episodes in the last six months
and five episodes in the last 12 months).
Stafford 1986 was conducted in the UK, probably in the early
1980s. The study “randomly” allocated 40 patients referred by
their general practitioners. Patients over 16 years oldwere included
if they had a history of at least four episodes of tonsillitis per year
in the two preceding years, each of these episodes consisting of
sore throat, dysphagia, fever and general malaise for at least three
days.
Interventions and comparisons
Children
Participants in the treatment arm of the van Staaij 2004 trial re-
ceived adenotonsillectomy, while those in Lock 2010 could re-
ceive either tonsillectomy (dissection or bipolar diathermy accord-
ing to surgical preference) or adenotonsillectomy (tonsillectomy
with adenoid curettage). The control arms of both studies received
“standard” medical treatment.
The Paradise studies had treated tonsillectomy and adenotonsillec-
tomy as different intervention arms. In Paradise 1984, the results
were reported together. Paradise 2002a and Paradise 2002b were
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two trials that ran in parallel. Paradise 2002b included children
with one or more indications for adenoidectomy (obstructing ade-
noids or history of recurrent or persistent otitis media) assigned
randomly into adenotonsillectomy or control non-surgical inter-
vention (two-arm trial). Paradise 2002a only included patients
with no indications for adenoidectomy and they were randomly
assigned to tonsillectomy, adenotonsillectomy or control (three-
armed trial). In the Paradise studies, the protocol for managing
suspected sore throat involved taking a culture and prescribing
penicillin if the culture was positive.
Adults
The participants in the treatment arm of the two studies in adults
received a tonsillectomy as soon as possible after randomisation.
All patients had tonsillectomy (total capsular tonsillectomy using
blunt or diathermy dissection), except one (who received adeno-
tonsillectomy in Koskenkorva 2013). Both studies used “watch-
ful waiting” as the control group. The control groups ’waited’ for
between three and six months in Alho 2007 and between five and
six months in Koskenkorva 2013.
Patients from both arms were advised to see their general prac-
titioner (GP) whenever they had acute symptoms suggestive of
pharyngitis. No specific treatment protocol was stated, although
participants were also given information about the study for their
GP, along with instructions about examining their ear, nose and
throat status, how to take cultures and obtain the relevant blood
samples.
In the Stafford 1986 study, participants in the surgery group un-
derwent tonsillectomy within six weeks of trial entry. In the non-
surgical group, the participants’ general practitioners (GPs) pre-
scribed an eight-day course of antibiotics for each episode of ton-
sillitis in the following year. Patients in this group were allowed to
“opt out” and have surgery at any time. Patients who had surgery
were reviewed every six months, up to the 18th month post-
surgery. Patients in the antibiotics group were reviewed every three
months in the outpatient clinic, and their GPs were sent study
protocols and questionnaires, which they completed and returned
to the investigators whenever the patients sought treatment (and
received antibiotics) for tonsillitis. A final review was carried out
between 18 and 24 months after entry to the trial.
Outcomes
The Paradise studies followed up participants over three years. A
standardised in-person or telephone inquiry was made bi-weekly
concerning the day to day occurrence of a specific list of symptoms
and events, and standardised clinical examination was performed
every six weeks and at the time of respiratory illness (Paradise
1984).
Both Lock 2010 and van Staaij 2004 collected data through patient
diaries. In van Staaij 2004, parents performed additional daily
temperature measurements using an electronic thermometer that
stored data, and these data were collected along with data from
diaries and quality of life questionnaires during follow-up visits
at 3, 6, 12, 18 and 24 months. Participants in Lock 2010 were
supposed to return the four-weekly diary by post, but telephone
prompt interviews were introduced “part way through the study”
due to low response rates to the health diary.
Measures of sore throat and sore throat days
Participants in two studies in adults were instructed to see their
GP when they had signs and symptoms suggestive of pharyngitis,
and instructions were given about collection of data from medical
examination and throat culture (Alho 2007; Koskenkorva 2013).
Data were also collected by symptom diaries.
All studies reported the number of episodes of sore throat and
number of days with sore throat, except for Stafford 1986. How-
ever, there were variations in how studies defined what is consid-
ered a sore throat episode or a sore throat day, and whether the
episode of pain and days of pain following surgery were included
in their report of number of episodes of sore throat and sore throat
days.
Based on the data reported, for childrenwewere able to standardise
the report of sore throat episodes to ensure all studies in children
included the episode due to the surgery. No standardisation was
required for sore throat days in children as all the included studies
already included the postoperative days in their data sets.
The situation was different in adults. Both included studies ex-
cluded the episode of postoperative sore throat in those partici-
pants undergoing surgery and any days of sore throat due to the
surgery.
Definition of sore throat episodes and days
The definition of what is considered an episode of sore throat and
sore throat days varied:
• In the Paradise studies, results for episodes of ’throat
infection’ are reported in four ways: (a) ’moderate or severe’
(based on a scoring system), (b) streptococcal, (c) ’counting’
(characterised by one or more qualifying clinical features of
episodes used in determining trial eligibility), and (d) ’all
combined’ (Paradise 1984; Paradise 2002a; Paradise 2002b).
• In the van Staaij 2004 trial, an episode ’throat infection’ was
defined as sore throat or pain or difficulty swallowing combined
with fever, whilst an episode of ’sore throat’ was defined as sore
throat or pain or difficulty swallowing with or without fever.
• In the Lock 2010 trial, an episode of sore throat was
defined as at least three consecutive days with sore throat. Any
consecutive recording of sore throat interrupted by four days of
non-recording constitutes a new episode.
• Alho 2007 primarily looked for pharyngitis due to group A
Streptococcus with a positive culture, and secondarily for ’all
episodes of pharyngitis’.
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• In the Koskenkorva 2013 trial, an episode of sore throat
was defined as at least two consecutive days with sore throat.
• Stafford 1986 only reported the proportion of patients who
“felt” their symptoms were “cured” after 18 months. This study
did not report the number of episodes of sore throat or their
severity.
Compared to the more specific categories (a), (b) and (c), the Par-
adise category (d) - ’all combined’ includes a broader spectrum
that is more analogous to the van Staaij 2004 category of ’sore
throat episode’ than ’throat infection’. Thus, in this review, the
data on ’episodes of sore throat of any severity’ refer in the Par-
adise studies to the ’all types combined’ category (Paradise 1984;
Paradise 2002a; Paradise 2002b), and in the van Staaij 2004, Lock
2010 and Koskenkorva 2013 trials to the ’episodes of sore throat’
data. For the Alho 2007 study, this refers to the “all episodes of
pharyngitis” data rather than “pharyngitis due to group A strep-
tococcus”.
We also extracted the more severe sore throat episodes defined
as ’moderate or severe’ (Paradise 1984; Paradise 2002a; Paradise
2002b) and ’throat infection’ (van Staaij 2004). In our analyses
these two categories are assumed equivalent; we recorded and anal-
ysed these as ’moderate or severe’ episodes.
In all the Paradise studies a ’sore throat day’ was defined as one on
which a sore throat lasted an hour or longer. The comparable data
from the van Staaij 2004 and Lock 2010 trials were the number
of sore throat days.
Other outcomes
None of the studies stated an intention to record, and nor did they
report, consumption of antibiotics or analgesics as outcomes. The
studies also did not pre-specify which data on complications or
morbiditywould be collected and reported, apart from the number
of days of pain post-surgery.
Koskenkorva 2013 measured quality of life using the Glasgow
Benefit Health Inventory, but this was done only for the tonsil-
lectomy group. van Staaij 2004 used the TACQoL or TAPQoL
but did not reported results in a way that could be meta-analysed.
Lock 2010 used the PedsQoL.
Excluded studies
After reviewing the full text, we excluded seven studies. Four were
non-randomised cohort studies (Clayburgh 2011; Kaiser 1930;
Naibo lu 2010; Stalfors 2012). We excluded three trials because
it was not clear whether the included children had suffered from
recurrent acute or chronic tonsillitis, as trial entry criteria were
poorly defined (Mawson 1967; McKee 1963; Roydhouse 1970).
See Characteristics of excluded studies.
Risk of bias in included studies
Summary assessment of risk of bias
We judged the methodological quality of most included trials to
be moderate: see the ’Risk of bias’ graph (Figure 2). Details of the
risk of bias in the included studies are presented in the ’Risk of
bias’ summary (Figure 3). We acknowledge that it is impossible
for the patients in any tonsillectomy trial to be unaware of their
group allocation. The two adult trials were at less risk of bias than
the trials involving children, but this was almost entirely related
to small losses to follow-up, as a result of short follow-up periods
(Alho 2007; Koskenkorva 2013).
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The method of random sequence generation was adequately de-
scribed in six of the eight trials, whereas it was unclear in two tri-
als (Paradise 1984; Stafford 1986). Furthermore, concealment of
allocation was not adequately described in three (Paradise 1984;
Stafford 1986; van Staaij 2004) (see Figure 3 and also the ’Risk of
bias’ tables in Characteristics of included studies).We had concern
about the effectiveness of allocation concealment when blocked
randomisation using small blocks of three or four patients was
used in these non-blinded studies and there was no description of
the methods used to conceal the allocation of existing participants
from the team members in charge of recruitment or enrolment of
patients (Paradise 2002a; Paradise 2002b).
In one trial baseline characteristics appeared to be imbalanced
(Paradise 1984). The children in the surgery groups (tonsillectomy
alone or adenotonsillectomy) differed from the control group in
terms of the history of episodes of throat infectionbefore entry into
the study and in terms of parental socioeconomic status (Paradise
1984, table 1). Those in the surgical group were more often ad-
mitted to the trial on the basis of frequent infection in the year
prior to entry rather than less frequent infections over a longer
period. At the time of our original review we felt that this imbal-
ance may make interpretation of the results problematic (Burton
1999). However, in his response to our review (see ’Feedback’ be-
low), Professor Paradise indicates that a number of children met
more than one of the frequency-related eligibility criteria (seven
or more episodes per year for one year, or five per year for two
years, or three per year for three years) and that such children were
categorised as meeting the criterion involving the largest number
of episodes. It seems that by chance more children in the surgi-
cal rather than the control group met the seven plus episodes per
year for one year criterion. We stated in the original review that
“The surgical group may therefore have included children with
more severe disease” and we still believe that this is a possibility.
However, as Professor Paradise points out, the resulting bias would
favour control subjects and result in a potential underestimation
of the treatment effect.We went on to say “Alternatively, these [the
children entered because of seven plus episodes in one year] may
have been children with less severe, but more short-lived disease in
whom a period of frequent infections is more likely to be followed
by spontaneous resolution than in those with longer more chronic
histories”. We accept the observation that some of these children
may also have had episodes in previous years, but would continue
to argue that our own comment is not counterintuitive. Theremay
be a difference between those children who have a short, relatively
brief, period with many sore throats in whom spontaneous reso-
lution then occurs, and those who experience several sore throats
per year for many years. A second baseline imbalance was noted.
The children in the non-surgical group were more likely to have
parents with higher socio-economic status than those in the sur-
gical group. Professor Paradise argues that this difference is likely
to favour the control group and again lead to an underestimation
of any treatment effect.
Blinding
None of the included trials performed blinding of trial participants
due to the nature of the intervention and control treatment. In
one trial, researchers who conducted interviews or processed self
completed questionnaires/diaries were blind to the interventions
of trial participants (Lock 2010). As the main outcomes of the
studies were reported by patients (mostly using patient diaries),
there was a risk of detection bias.
Incomplete outcome data
All trials reported the numbers of participants who failed to com-
plete the trial and the number of patients excluded.
In seven of the eight included trials intention-to-treat analysis was
performed - all patients were analysed according to the group to
which they were randomised. In one trial, children in the control
group who elected to have surgery and those that did not complete
the whole follow-up period were excluded from analysis (Paradise
1984).
In four of the five trials on the effectiveness of adeno-/tonsillectomy
in children, we judged the risk of attrition bias to be high due
to the large number of participants lost to follow-up (Lock 2010;
Paradise 1984; Paradise 2002a; Paradise 2002b). In one study, the
trial was stopped at a fixed time period (van Staaij 2004). Although
the loss to follow-up in this trial was relatively low, only about half
of the children were enrolled at a time point which allowed them
to complete a two-year follow-up period.
In the Lock 2010 trial, loss of participants to follow-up at the end
of the first and second years was not the only potential source of
significant attrition bias. For individual participants, the data sets
were incomplete. Data were collected using monthly diaries and
self completed postal questionnaires. The mean number of diaries
returned per child in the trial was 9.91 out of 24. As a result, it
is difficult to work out how the outcome data relating to “mean
number of episodes of sore throat per month” or “mean days of
sore throat” were calculated. The study reported that the mean
episodes and days with sore throat outcomes were estimated by
taking the average of the numbers reported per (four-week) diary
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returned and multiplying that by 26 to get the rate over two years.
It is possible that the diaries weremissing in a non-randommanner
(differential missing rate), introducing a significant risk of bias.
The study report noted that there was a possible overestimation of
the number of episodes and days with sore throat. When the study
authors adjusted for the number of diaries a child returned, the
weighted mean number of sore throats decreased over two years
from 11.4 to 9.0 for the control group and from 7.4 to 5.5 in the
surgery group. We conducted a sensitivity analysis to investigate
the impact of inclusion of these trial data in the analysis.
There were a large number of missing data sets in the second and
third years of the trials and a large proportion of patients receiving
surgery (see Other potential sources of bias), therefore we only
included data from the first 12 months of follow-up (Lock 2010;
Paradise 1984; Paradise 2002a; Paradise 2002b). The authors of
the van Staaij 2004 trial kindly provided us with data on the
outcomes at one year.
We judged the risk of attrition bias in the two trials on the effec-
tiveness of tonsillectomy for recurrent pharyngitis in adults to be
low (Alho 2007; Koskenkorva 2013; Stafford 1986). There were
no losses to follow-up. In one trial, 6% (2/34) of the participants
allocated to the control treatment received tonsillectomy during
follow-up (Alho 2007), while in the other trial this percentage was
8% (3/40) (Koskenkorva 2013). In the third trial, six out of 20
patients (30%) had received tonsillectomy by the end of the two-
year study follow-up (Stafford 1986). In all these trials, all partic-
ipants allocated to tonsillectomy received surgery.
In studies where patients were analysed according to the groups
to which they were randomised, the percentage of patients in the
control arm receiving surgerywithin the first year of randomisation
ranged from 6% and 8% (as above) to 15% in the Paradise studies
within the first year of follow-up (Paradise 1984; Paradise 2002a;
Paradise 2002b). Only the overall number of children (over the
entire duration of the trial) receiving surgery in the control arm
were available for Lock 2010 and van Staaij 2004 and these were
26% (36/137) and 34% (50/149), respectively.
Data on the losses to follow-up and the number of patients in
control groups receiving surgery are provided in the ’Risk of bias’
tables (Characteristics of included studies).
Selective reporting
We did not have access to study protocols and we did not have
enough information to assess the risk of selective reporting bias.
Without sufficient information, we judged the risk of bias from
selective reporting to be unclear.
As there were only a few studies, we could not conduct formal
assessment using funnel plots.
Other potential sources of bias
Baseline characteristics appeared to be balanced in six of the seven
trials (Alho 2007; Koskenkorva 2013; Lock 2010; Paradise 2002a;
Paradise 2002b; van Staaij 2004).
There is a risk of underestimating the effectiveness of surgery
when large numbers of patients in the control group also undergo
surgery. This risk appears to be relatively low when the follow-up
period is short, but high over periods of two years or more. The
proportion in the control group receiving surgery was 6% and 8%
for Alho 2007 and Koskenkorva 2013, respectively; they followed
up patients for an average of six months. The Paradise studies re-
ported the number of patients receiving surgery at each yearly time
point. The cumulative rate was 8% (Paradise 2002a) and 15%
(Paradise 1984; Paradise 2002b) over one year, and 11%, 22%
and 25% respectively after two years. In the only adult study that
collected data for more than a year, the percentage of participants
opting for surgery within two years was 30% (Stafford 1986).
Lock 2010 and van Staaij 2004 only reported the overall number of
children in the control group receiving surgery, i.e. 50/149 (34%)
in van Staaij 2004 and 36/137 (26%) in Lock 2010.
Effects of interventions
See: Summary of findings for the main comparison
Tonsillectomy or adenotonsillectomy versus no surgery in children
with chronic/recurrent acute tonsillitis
Although all the studies on the effectiveness of adeno-/tonsillec-
tomy in children extended over several years, large losses to follow-
up mean that for the majority of studies sufficient data are only
available to allow consideration of results in the first year following
surgery. We therefore only included data from the first 12 months
of follow-up from the five trials on the effectiveness of adeno-
/tonsillectomy in children (Lock 2010; Paradise 1984; Paradise
2002a; Paradise 2002b; van Staaij 2004), and up to six months for
the two trials in adults (Alho 2007; Koskenkorva 2013). Stafford
1986 had no losses to follow-up, but did not report any of the
outcomes we planned to analyse.
We analysed results in the following way:
• Analysis 1: Tonsillectomy/adenotonsillectomy versus no
surgery in children.
• Analysis 2: Tonsillectomy/adenotonsillectomy versus no
surgery in adults.
• Analysis 3: Sensitivity analysis of the effect of combining
adenotonsillectomy and tonsillectomy versus tonsillectomy
alone.
• Analysis 4: Sensitivity analysis based on the risk of bias of
included studies.
As baseline severity and frequency of tonsillitis could be factors
that affect the results, we analysed the data for children as two sub-
groups: ’severely affected patients’ (Paradise 1984) and ’moderately
affected patients’ (Lock 2010; Paradise 2002a; Paradise 2002b;
van Staaij 2004).
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The individual results of the seven trials are summarised in
Appendix 3.
Tonsillectomy or adenotonsillectomy versus no
surgery
1. Number and severity of episodes of tonsillitis or sore
throat
This outcome was measured in two ways in the trials. Some trials
only reported episodes of sore throat of any severity, whereas others
also reported episodes of ’moderate/severe’ sore throat.
Studies conducted in children
Episodes of sore throat of any severity
The first analysis demonstrates the number of episodes of sore
throat of any severity including the immediate postoperative pe-
riod (Analysis 1.1). In this instance we analysed the data using
the random-effects model because of the presence of substantial
statistical heterogeneity (I2 = 57%). Surgery is associated with 0.6
fewer sore throat episodes of any severity (95% confidence interval
(CI) -1.0 to -0.1 episodes). Children who had an adeno-/tonsil-
lectomy had an average of three episodes of sore throats (of any
severity) in the first postoperative year, compared to 3.6 episodes
in the control group. The ’predicable’ episode of pain immediately
following surgery is, however, important in interpreting this figure
as this accounts for one of the three episodes in the surgical group.
We consider the evidence to be of moderate quality, due to lack
of standardised methods or definitions in reporting or measuring
episodes of sore throat in these studies (which are unblinded) and
some uncertainty due to missing data.
Tests for subgroup differences did not show a significant difference
between the more severely affected patients and those moderately
affected (P value = 0.56, I2 = 0%). We identified one study as
at a high risk of bias for this outcome, due to high proportion
of missing data (Lock 2010). We tested the impact of this study
in a sensitivity analysis. Removing this study did not have much
impact on the effect size (mean difference (MD) -0.42, 95% CI -
0.87 to 0.02) or heterogeneity.
Episodes of moderate/severe sore throat
In this analysis, the test for subgroup differences between themore
severely affected patients and those moderately affected was statis-
tically significant (P value = 0.0003) (Analysis 1.2), therefore we
did not pool the subgroups.
Children who had been more severely affected and had adeno-/
tonsillectomy had on average 1.1 episodes of sore throat in the
first postoperative year, compared with 1.2 episodes in the control
group; a small difference of 0.1 episodes (95% 0.6 fewer to 0.4
more) (Paradise 1984). This is not a significant difference but one
episode in the surgical group was that occurring immediately after
surgery. There may be a benefit to knowing the precise timing
of one ’predictable’ episode of pain lasting several days following
surgery.We considered the results to be of low quality as they came
from one small randomised controlled trial (RCT) and there were
more missing data/excluded patients in the control group.
Less severely affected children had more episodes of moderate/
severe sore throat after surgery (1.2 episodes) than in the control
group (0.4 episodes): a difference of 0.8 episodes (95% CI 0.7 to
0.9 episodes), but again one episode was the postoperative episode.
We rated the evidence as moderate quality.
Studies conducted in adults
Episodes of sore throat of any severity
There was substantial statistical heterogeneity in this analysis (I
2 = 94%) (Analysis 2.1) and we analysed the results using the
random-effects model. There were 3.6 fewer episodes in the group
receiving surgery within six months post-surgery (95% 7.9 fewer
to 0.7 more). We rated this evidence as low quality because of
the short duration of follow-up (indirectness of evidence) and
inconsistency. The difference in effect sizes reported by the two
studies is substantial; the reduction was 1.5 fewer episodes (95%
CI 2.3 fewer to 0.7 fewer) in Alho 2007 and 5.9 fewer episodes
(95% CI 7.8 fewer to 0.7 fewer) in Koskenkorva 2013. When
interpreting these findings, it should be noted that the episode of
sore throat following surgery has not been included in this analysis.
Episodes of moderate/severe sore throat
The two studies in adults did not distinguish between types of sore
throat in ways that were comparable with the studies performed
in children.
2. Number of days with sore throat
Studies conducted in children
In themeta-analysis on sore throat days, the number of sore throat
days is about five days less in the surgical group (-5.1 days, 95%
CI -8.1 to -2.2) (Analysis 1.3). The number of days with pain after
surgery has been included in this analysis. Therefore the clinical
correlate of this is that rather than having about 23 days of sore
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throat in the year, children receiving surgery had 18 days of sore
throat, of which some (between five and seven on average) were
immediately following surgery and, as such, entirely predictable.
There was some statistical heterogeneity (I2 = 43%), but this was
reduced if data from Lock 2010 were excluded from the analysis
(then the I2 = 0%, P value = 0.59). We previously noted that
this study had a high risk of bias in overestimating the number
of days and episodes of sore throat due to the high percentage of
missing data. Removing Lock 2010 from the analysis reduced the
mean difference by about one day to 4.3 days (difference -4.3 days,
95% CI -8.0 to -1.3). Due to these concerns, and the absence of
blinding, we considered the evidence to be of moderate quality.
Studies conducted in adults
Unlike the studies in children, the studies in adults did not include
the number of days post-surgery in their analysis (see Analysis 2.2).
There was significant statistical heterogeneity (I2 = 85%) and we
analysed the results using the random-effects model. The pooled
mean difference for number of days with sore throat for about six
months of follow-up was 10.6 days fewer in the group receiving
surgery (95% CI -15.5 to -5.8). The difference in the effect sizes
reported by the two studies is substantial; the reduction in mean
number of days with pain varied from 8.9 days fewer (95% CI
-14.0 to -3.9) in Alho 2007 to 35.1 days fewer (95% CI -54.0
to -16.2) in Koskenkorva 2013. As previously noted, the number
of days with sore throat in the immediate postoperative periods
is not taken into account in this analysis, which appeared to be
13 (standard deviation (SD) 4) days in Alho 2007 and 17 (SD 6)
days in Koskenkorva 2013. In addition, the data in Koskenkorva
2013 are potentially skewed (large standard deviations observed).
We considered the evidence for this outcome to be low quality due
to these concerns.
3. Morbidity and mortality of surgery
None of the studies listed mortality as an outcome and none re-
ported any deaths in the description of complications arising from
surgery.
None of the studies clearly stated which outcomes related to mor-
bidity or complications would be measured in the trials (apart
from the number of days with sore throat following surgery). Ton-
sillectomy is a painful procedure: the days with postoperative pain
might reasonably be considered clinically significant. These were
already included in the analysis of days of sore throat for children
(Analysis 1.3), but not for adults (Analysis 2.2).
For children, the Paradise 1984 trial reports a mean figure for the
number of days of pain after surgery as 4.9 days. In the later studies
a mean of 6.3 days is given, with a wide range from 0 to 21 days
(Paradise 2002a; Paradise 2002b).
In the two trials in adults (aged 13 years and older) (Alho 2007;
Koskenkorva 2013), the mean duration of continuous throat pain
following surgery was 13 days (SD 4) and 17 days (SD 6), respec-
tively.
Complications reported in the included studies are summarised in
Table 1. In four studies in children primary bleeding was reported
in 1.5% to 4.8%, while secondary bleeding was reported in 4.3%
and 6% in the two studies in adults.
4. Consumption of antibiotics
None of the studies specifically reported on antibiotic prescriptions
or consumption of antibiotics.
5. Consumption of analgesics
Only one study reported data for analgesics consumption (Lock
2010). The mean number of drugs prescribed was two per patient
over two years (SD 3.1) in the surgical arm (n = 120) and two (SD
2.6) in the control arm (n = 115).
6. Absence or time off work or school
Studies conducted in children
The results of combining all those children undergoing surgery
(tonsillectomy and/or adenotonsillectomy) versus (initial) non-
surgical treatment across all studies with follow-up for one year are
reported in Analysis 1.4. Children who had surgery had 2.3 fewer
days (95%CI -3.4 to -1.2) of absence from school compared to an
average of six days of absence among children in the control group.
We considered this evidence to be of moderate quality. However,
the days off school immediately following surgery are not included
in this analysis (and data in ’3. Morbidity and mortality of surgery’
above indicate this period to amount to five to six days on average).
Studies conducted in adults
Only Koskenkorva 2013 reported on this outcome. Absenteeism
was 3.3 days lower in the surgery arm, but this was not significant
(95% CI -7.7 to 1.1) (Analysis 2.3).
7. Quality of life
Three studies collected quality of life data, but these unfortunately
could not be pooled (Koskenkorva 2013; Lock 2010; van Staaij
2004)
Lock 2010 collected data at three months, 12 months and 24
months using the parent form of PedsQoL (Paediatric Quality of
Life Inventory). The amount of missing data at 12 months was
significant; only 64% of participants (71/111) in the surgery arm
and 48% of participants (52/108) in the control arm returned the
PedsQoL questionnaire.
van Staaij 2004 collected data for health-related quality of life using
the TNO-AZL (Netherlands Organisation for Applied Scientific
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Research Academic Medical Centre) Preschool Children’s Quality
Of Life Questionnaire (TAPQoL) for children aged two to five or
the TNO-AZL Children’s Quality Of Life Questionnaire (TAC-
QoL) for children aged five years and older and the Child Heath
Questionnaire - Parental Form (CHQ pf50). The study reported
that small differences were found in some domains of the quality
of life questionnaires at six months but these were “not clinically
relevant”. No differences were found in the other domains or at
24 months.
Koskenkorva 2013 used a post-intervention questionnaire (Glas-
gow Benefit Inventory, GBI), which was only applied to the in-
tervention group.
The quality of life data are summarised below.
Study Quality of life instrument Scale Score
Lock 2010a PedsQoL Physical health Surgery: 90.0 (SD 16.4), n = 71
Control: 85.3 (SD 17.9), n = 52
Psychosocial health Surgery: 83.8 (SD 15.3), n = 71
Control: 80.0 (SD 17.5), n = 52
van Staaij 2004 Arcola or TAPQoL
CHQ - parental form
All subscales “No difference” at 24 months
Koskenkorva 2013b Glasgow Benefit Inventory (GBI)
(Scale range from -100 (maximal
negative benefit) to 0 (nobenefit) to
+100 (maximal benefit) Robinson
1996)
Data were only collected from the
tonsillectomy group
Overall score 27 (SD 12)
General health subscore 23 (SD 15)
Social subscore 3 (SD 12)
aLock 2010: table here shows the 12-month data.
bKoskenkorva 2013: data were only available for the intervention
group. The GBI is a generic post-intervention questionnaire that
assesses the effects of surgery on the health status of patients.
Tonsillectomy versus adenotonsillectomy
Data from the Paradise 2002a study allowed direct comparison be-
tween tonsillectomy and adenotonsillectomy. No significant dif-
ferences were found in either the number of episodes of sore throat
or sore throat days. As reported above, in an earlier trial results
from those children undergoing tonsillectomy and adenotonsillec-
tomy were combined because no differences between the groups
were observed (Paradise 1984).
For this update we undertook an appropriate sensitivity analysis by
analysing these as subgroups.Wedidnot observe any heterogeneity
in treatment effects between different types of surgery (Analysis
3.1; Analysis 3.2; Analysis 3.3), but this should be interpreted
with caution as this analysis may not be powered to detect small
differences, and it is possible that such differences could bemasked
by other forms of clinical heterogeneity present between studies.
Overall, we may never know whether the absence of evidence of a
difference between the effects of the procedures is because no such
difference exists, or is due to a lack of statistical power to detect a
difference. There remains doubt about whether or not removing
the adenoids (reducing or preventing as it does the incidence of
mouth breathing) has an effect on the frequency and/or severity
of sore throats.
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Effectiveness of surgery after the first postoperative
year
Four of the five included trials suffered from substantial loss to
follow-up, especially during the second and third year of the trials
(Lock 2010; Paradise 1984; Paradise 2002a; Paradise 2002b). As
a consequence, good information was only available for the first
12 months.
In the previous version of this review we presented data from the
van Staaij 2004 trial and suggested that it might be possible to
draw some tentative conclusions from these data about the effect
of tonsillectomy in the second postoperative year. However, hav-
ing clarified the methods underlying the data (see the individual
results section in Appendix 3), it is not possible to determine what
happened to participants specifically in the second year of follow-
up. The study does include data from 139 participants who were
followed up for 23 months, of whom 80 participants were fol-
lowed for two years. However, data on the frequency and duration
of sore throats during that second year alone are not available. The
proportion of the 174 participants who spent 23 months in the
trial, who were lost to follow-up, is 20% and therefore similar to
the other studies.
Stafford 1986 only reported the number of patients who “felt”
their symptoms were “cured” after 18 months. This is neither a
predefined outcome in our analysis protocol, nor one that could be
pooled with other studies. Between 18 months and two years after
enrollment, 18/20 participants in the surgery group versus 14/20
participants in the antibiotics group felt that their symptoms were
“cured” (risk ratio 0.86, 95% CI 0.57 to 1.29).
D I S C U S S I O N
Summary of main results
• This review includes seven trials with low to moderate risk
of bias: five undertaken in children (987 participants) and two in
adults (156 participants). Good information about the
effectiveness of adeno-/tonsillectomy is only available for the first
year following surgery in children and for a shorter period (five
to six months) in adults
• We combined data from five trials in children. Those
children who had an adeno-/tonsillectomy had an average of
three episodes of sore throats (of any severity ) in the first
postoperative year, compared to 3.6 episodes in the control
group; a difference of 0.6 episodes (95% confidence interval (CI)
-1 to -0.1; moderate quality evidence). One of the three episodes
in the surgical group was the ’predictable’ one that occurred in
the immediate postoperative period.
• When we analysed only episodes of moderate/severe sore
throat, children who had been more severely affected and had
adeno-/tonsillectomy had on average 1.1 episodes of sore throat
in the first postoperative year, compared with 1.2 episodes in the
control group (low quality evidence). This is not a significant
difference but one episode in the surgical group was that
occurring immediately after surgery.
• Less severely affected children had more episodes of
moderate/severe sore throat after surgery (1.2 episodes) than in
the control group (0.4 episodes: difference 0.8, 95% CI 0.7 to
0.9), but again one episode was the predictable postoperative
episode (moderate quality evidence).
• Data on the number of sore throat days are only available
for moderately affected children and are consistent with the
data on episodes. In the first year after surgery children
undergoing surgery had an average of 18 days of sore throat (of
which some - between five and seven on average - will be in the
immediate postoperative period), compared with 23 days in the
control group (difference 5.1 days, 95% CI 2.2 to 8.1; moderate
quality evidence).
• Data for adults were only available for analysis for up to
five to six months of follow-up. When we pooled data from two
studies (156 participants), there were 3.6 fewer episodes (95%
CI 7.9 fewer to 0.70 more; low quality evidence) in the group
receiving surgery within six months post-surgery. However,
statistical heterogeneity was significant. The pooled mean
difference for number of days with sore throat in a follow-up
period of about six months was 10.6 days fewer in favour of the
group receiving surgery (95% CI 5.8 fewer to 15.8 fewer; low
quality evidence). Again there was significant statistical
heterogeneity in this analysis and the number of days with
postoperative pain (which appeared to be on average 13 to 17
days in the two trials) was not included. Given the short
duration of follow-up and the differences between studies, we
considered the evidence from adults to be of low quality.
• Two studies in children reported that there was “no
statistically significant difference” in quality of life outcomes but
the data could not be pooled. One study reported no difference
in analgesics consumption. We found no evidence for
prescription of antibiotics.
Overall completeness and applicability of
evidence
In evaluating the data from the available trials of adeno-/tonsillec-
tomy for chronic or recurrent acute tonsillitis or sore throats there
are several issues that must be considered.
• Only one study examines the effectiveness of adeno-/
tonsillectomy in severely affected children (children with the so-
called ’Paradise criteria’ for surgery).
• Most trials included children with more modest symptoms
and disease.
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• It is not possible to determine whether or not the
effectiveness of tonsillectomy and adenotonsillectomy are
different.
• Adequate data are only available to evaluate the
effectiveness of adeno-/tonsillectomy in children in the first
postoperative year due to substantial loss to follow-up in the
included trials, especially in the second and third years.
• Three trials assessed the effectiveness of tonsillectomy in
adults, but only data from the short-term studies (duration of
follow-up five to six months) could be pooled. One trial
determined the short-term effectiveness of tonsillectomy in one
specific subgroup of patients (recurrent episodes of pharyngitis
due to group A Streptococcus), while the other trial reported the
short-term effectiveness of tonsillectomy in patients with
recurrent episodes of pharyngitis of any origin. The trial that
reported data up to 24 months was small (40 participants), at
high risk of bias and only reported the proportion of patients
who “felt cured”.
• There are no trials evaluating the intermediate to long-term
effectiveness of tonsillectomy in adults (other than one at high
risk of bias).
While an adult or child who has had their palatine tonsils removed
cannot suffer from tonsillitis they can suffer from sore throats.
Unfortunately, the palatine tonsils are just one part of Waldeyer’s
ring of lymphoid tissue within the pharynx. The aggregates of
lymphoid tissue in the tongue base, nasopharynx and within the
pharyngeal walls, along with the remaining soft tissues of the phar-
ynx, remain after tonsillectomy. This, at least in part, explains why
tonsillectomy is not a panacea for all sore throats. Patients with
chronic or recurrent acute sore throats are heterogeneous in terms
of both causation and severity. Some have symptoms primarily
due to infection of the tonsils, others do not. Thus an important
issue is the role the palatine tonsils play in producing the clinical
condition of ’tonsillitis’, or indeed ’sore throat’ or ’throat infection’.
It is self evident that removal of the palatine tonsils will prevent
’tonsillitis’ just as removing the appendix will prevent appendicitis.
However, many patients with ’tonsillitis’ will have inflammation,
or infection, of other pharyngeal lymphoid tissue and other soft
tissues of this region. If inflammation/infection of these tissues
is critically dependent on inflammation/infection of the tonsils
themselves, tonsillectomy might be effective. If inflammation/in-
fection of non-tonsillar tissue is independent of tonsillar infection,
removing the tonsils may be irrelevant.
Children
The studies provide limited information on the effectiveness of
adeno-/tonsillectomy in certain types of children. While some of
the children probably suffered from a clinical condition in which
the palatine tonsils played a major (perhaps exclusive) role in the
pathogenesis of their symptoms and signs, others might have been
included in whom the palatine tonsils were not the source of their
symptoms. In his initial study, Paradise tried extremely hard to
identify children who fell into the first group (Paradise 1984). As
a result the ’Paradise criteria’ have become widely recognised as a
standard set of criteria for children with severe throat symptoms
due to tonsillar disease in whom tonsillectomy is being considered.
Equally, when following up children post-randomisation, Paradise
had strict criteria for episodes of throat infection. The later Par-
adise studies specifically looked at less severely affected children
and it is certainly possible that this group included children in
whom the palatine tonsils played a less important role in their
symptoms (Paradise 2002a; Paradise 2002b). The van Staaij 2004
trial is unique because the eligibility criteria were much broader.
Any child whose ENT surgeon felt they should undergo adeno-
/tonsillectomy was potentially eligible. Those fulfilling the ’Par-
adise criteria’ were excluded, leaving as the included group chil-
dren who might have been similar to the Paradise (2002) ’less
severely affected’ children (Paradise 2002a; Paradise 2002b).How-
ever, equally, some children may have fulfilled even less strin-
gent criteria. To reiterate, these were children who ENT surgeons
working in 21 general hospitals and three academic centres in the
Netherlands had deemed fulfilled their normal criteria for surgery.
Whilst specific information on the nature and severity of sore
throats prior to randomisation is lacking in the van Staaij 2004
trial, no such criticism can bemade of the follow-up period. A sore
throat was defined as sore throat or pain or difficulty in swallowing
combined, with or without a fever. The study by Lock 2010 ini-
tially included both children experiencing mild symptoms (six or
more episodes within two years or eight or more episodes within
one year) and moderate symptoms (sore throat for five days or
more: six or more episodes within two years or six or more within
one year). These stringent criteria were, however, amended mid-
way through the study and the inclusion criteria were changed to
include children experiencing four or more episodes of sore throat
within each of two years or six or more episodes of sore throat
within one year. As a consequence the entry criteria for inclusion
in this trial were less stringent than those of Paradise 1984.
In summary, what the included studies actually evaluate is the ef-
fectiveness of adeno-/tonsillectomy for the symptoms experienced
by three more or less heterogeneous groups of children, and these
studies themselves are heterogeneous.
• In Paradise 1984 many (possibly most) included children
had symptoms related to their palatine tonsils so this group is
likely to be least heterogeneous.
• Paradise 2002a, Paradise 2002b and Lock 2010 had a
heterogeneous group of less severely affected children. What
proportion had symptoms related to their palatine tonsils?
• van Staaij 2004 had potentially the most heterogeneous
group of less severely affected children. Again, the proportion
with symptoms related to their palatine tonsils is uncertain.
Is it, therefore, rational to combine the studies given the clinical
heterogeneity among the included study populations of the trials?
Combining results would probably lead to an underestimate of a
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positive treatment effect from surgery in themost severely affected
children and an overestimate in the least severely affected.
Severely affected children
Is there a positive treatment effect in the most severely affected
children? These children from Paradise 1984 are included in our
first meta-analysis (Analysis 1.1; Analysis 1.2; Analysis 1.3). In
terms of moderate/severe sore throat, the benefit of adeno-/ton-
sillectomy is exchanging the 1.2 episodes experienced by the con-
trol group for 1.1 episodes following surgery at a ’cost’ of the one
episode following surgery, which means the children had only an
average of 0.1 fewer episodes. The postoperative episode might
be thought to be preferable because it can be timed and antic-
ipated. However, this is at best a modest benefit and, given the
width of the confidence interval (95% CI 0.6 fewer to 0.4 more),
the true value may be even less. The commensurate reduction in
any type of sore throat was 0.9 episodes (3.1 versus 2.2 (= 1.2 +
1 episode post-surgery)). No significant reduction was found in
terms of number of sore throat days in the first year (18.9 in the
control group versus 16.3 in the adeno-/tonsillectomy group) but
(on average) five to seven of these 16.3 days were in the immediate
postoperative period and hence highly predictable. Since there are
no ’post-surgical days’ in later years, one might speculate that had
sufficient data been available for the second and third years post-
surgery, a difference may have been seen.
Less severely affected children
As might be expected, the benefits seen in the less severely affected
children are less (Analysis 1.1; Analysis 1.2; Analysis 1.3), with
a increase in moderate or severe sore throat episodes of 0.8, and a
decrease of any sore throat of 0.5, if the episode of pain due to
surgery is taken into account. In this analysis there was a statisti-
cally significant reduction in sore throat days from 24 to 18 days.
That period of 18 days includes the predictable five to seven days
of pain in the immediate postoperative period.
Effects in the second year post-surgery
Little useful information is available about the effects of surgery
in the second postoperative year and beyond.
Adults
Two trials examined the short-term effectiveness of tonsillectomy
in adults (Alho 2007; Koskenkorva 2013). One trial focused on a
specific subgroup of patients (recurrent episodes of pharyngitis due
to group A Streptococcus), while the other trial included patients
with recurrent episodes of pharyngitis from any origin. Although
both studies suggest that tonsillectomyoffers short-termbenefits as
compared to (initial) non-surgical treatment, the limited duration
of follow-up prevents us from drawing firm conclusions. We must
conclude that we do not know, one way or the other, whether
tonsillectomy is generally helpful for adults suffering from sore
throats in the intermediate or long term. If we could be certain
that (a) the symptoms were solely attributable to inflammation
of their tonsils, and (b) these symptoms were going to continue,
then tonsillectomy would be a reasonable treatment option. It
is difficult (if not impossible) to be certain that both of these
conditions are true for an individual patient. Although a third
trial reported percentages of people who “felt cured”, the trial had
many limitations and the effect size observed was not significant.
Quality of the evidence
We judged the evidence for the primary outcomes for children’s
data to be of moderate quality; we downgraded the evidence from
high quality mainly due to the high number of losses to follow-
up that introduced a substantial risk of (attrition) bias, especially
beyond one year after surgery, and also due to inconsistencies in
the data collection.
Most of the evidence is derived from trials in children and there is
a lack of data for adults, particularly after six months of follow-up.
There was also significant heterogeneity observed in the data for
adults. Therefore, the quality of evidence for the main outcomes
for adults is low.
Potential biases in the review process
The outcome definitions and methods of data collection were
different between studies, introducing some clinical heterogeneity.
However, we did standardise the definition of key outcomes such
as (refraining from) including the number of days and episodes
of sore throat post-surgery in the meta-analyses. There was also a
concern about potential skewness from the use of count data for
episodes of sore throat.
Agreements and disagreements with other
studies or reviews
Our main results are in agreement with findings reported in a
recent (narrative) systematic review on the effects of tonsillectomy
for recurrent sore throats in children (Barraclough 2014), andwith
current clinical practice guidelines on tonsillectomy for children
and adults with recurrent sore throats (Baugh 2011; SIGN 2010).
The information about complications provided by the studies
included in this review is consistent with other published data
even though reporting may be incomplete. Relatively small ran-
domised controlled trials are often inadequate for providing ac-
curate data about rare complications. The best available data on
primary and secondary haemorrhage following tonsillectomy are
provided by the United Kingdom National Tonsillectomy Audit
(Brown 2005); the primary and secondary haemorrhage rates were
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0.6% and 3%, respectively, in a group of 33,921 patients who un-
derwent tonsillectomy over a 14-month period in 2003 and 2004.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Good information about the effectiveness of adeno-/tonsillectomy
is only available for the first year following surgery in children and
a shorter period (five to six months following surgery) in adults.
For more severely affected children (those who fulfil the ’Par-
adise criteria’), those who have an adeno-/tonsillectomy will have
a significant, but predictable episode of sore throat immediately
following surgery and then two other episodes in the first post-
operative year (1 predictable + 2 unpredictable = 3 in total) com-
pared with 3.6 unpredictable episodes in the control group. The
difference is 0.6 episodes, but with a confidence interval of -1 to
-0.1; in other words, the real difference may be one episode or
almost none. In practical terms, this difference is modest.
Less severely affected children who have adeno-/tonsillectomy
may never have had another moderate/severe sore throat anyway;
the chance of them so doing is modestly reduced by adeno-/ton-
sillectomy. For them, surgery will mean having an average of 1.2
moderate/severe sore throats (1 predictable + 0.2 unpredictable =
1.2 in total) rather than 0.4 unpredictable episodes experienced
by the control group. If the postoperative episode is set aside (and
this may not be a reasonable thing to do), there is no difference
in the number of unpredictable episodes of moderate/severe sore
throat. The children who have surgery will have 18 rather than 23
sore throat days but something between five to seven (on average)
of these 18 days will be in the immediate postoperative period.
Current evidence suggests that in adults with recurrent episodes of
pharyngitis tonsillectomy may not lead to a clinically significant
reduction in the number of sore throat episodes and sore throat
days in the first five to six months following surgery as compared
to (initial) non-surgical treatment.
The very modest benefits that have been identified should be care-
fully weighed against the possible harms of surgery, as the proce-
dure is associated with a small but significant degree of morbidity
in the form of primary and secondary haemorrhage and, even with
good analgesia, is particularly uncomfortable for adults.
Questions related to the natural history of recurrent/chronic
tonsillitis/’sore throat’
One reason why the impact of surgery is so modest is that many
patients in the control group get better spontaneously. There is
a trade-off for the physician and patient, who must weigh up a
number of different uncertainties. These are:
Uncertainty 1: Are my symptoms primarily attributable to disease
of my palatine tonsils?
Uncertainty 2: Am I going to continue to have sore throats and,
if so, will they be as bad, better or worse?
Decision: Do I want to exchange the uncertainties of both the
possibility and timing of my sore throats, in the year ahead, for the
certainty of a predictable period of postoperative pain that may be
followed by fewer sore throats than I might have had?
Many thousands of patients have undergone adeno-/tonsillectomy
and are likely to continue to do so. Some will undergo this surgery
’unnecessarily’ because they would not have had any further throat
problems had they not had surgery. During a period in the 1980s
and 1990s in the United Kingdom, when waiting lists for surgery
were long, a proportion of patients who were listed for surgery ac-
cording to strict criteria eventually declined the operation because
they had improved spontaneously. Perhaps the price society pays
for the prevention of recurrent sore throats in one group of patients
is that for each of these individuals an indeterminable number of
other individuals will have their tonsils removed ’unnecessarily’.
Those who choose surgery for themselves or their child must be
fully informed of the risks of the procedure; this is critical in con-
ducting the appropriate harm-benefit analysis. Evidence from the
included studies confirms that primary and secondary haemor-
rhages are still significant complications. Evenmore robust data are
provided by the United Kingdom National Tonsillectomy Audit,
undertaken between 2003 and 2004. The audit collected infor-
mation from 33,921 patients undergoing tonsillectomy (Brown
2005). Overall the rates of primary and secondary haemorrhage
were 0.6% and 3%, respectively; the rates varied according to the
surgical technique used to remove the tonsils.
Those considering tonsillectomy or adenotonsillectomy for them-
selves or their children, as a treatment for chronic or recurrent
acute tonsillitis, and those advising them, should be aware of two
important uncertainties that may affect their treatment decisions.
They must acknowledge some uncertainty about whether or not
their symptoms are primarily due to their tonsils and realise that
adeno-/tonsillectomy is not a panacea for all types of sore throat.
There is also uncertainty about the likelihood that these will con-
tinue in the future, which is only partly predictable from the fre-
quency and severity of symptoms they have experienced in the
past.
The benefits of surgery are greatest in children fulfilling the ’Par-
adise criteria’. In their original setting these were very strict, re-
quiring a child to have had each of the following: (1) seven or
more episodes in the preceding year, or five or more in each of
the preceding two years, or three or more in each of the preceding
three years, comprising (2) characteristic clinical features, having
been (3) treated with antibiotics when streptococcal infection was
proven or suspected, and (4) each episode had to have been be
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documented in a clinical record. In day-to-day practice these cri-
teria are often ’watered down’, with most emphasis being placed
on the aspect of ’counting’ the number of episodes, and less on
proving the ’certainty’ of each episode.
Surgery is associated with a reduction in the number of unpre-
dictable days with sore throat and the number of episodes of sore
throat even in those who are less severely affected. One of the key
practical issues is that the episode of a period of days with sore
throat that follows surgery is entirely predictable, lasting between
about five and seven days on average, but in some cases being
shorter and in others considerably longer. These benefits should be
carefully weighed against the possible harms of surgery as adeno-
/tonsillectomy is associated with a small but significant degree of
morbidity in the form of primary and secondary haemorrhage
and, even with good analgesia, is particularly uncomfortable for
adults. It may have to be accepted that some patients will undergo
’unnecessary surgery’ in order for others to benefit, and that even
well-informed and appropriately counselled patients are prepared
to accept the risks and uncertainty of surgery.
Implications for research
Evidence
One implication drawn from the trials is that greater benefit can
potentially be obtained by more severely affected children. If the
’Paradise’ criteria are accepted for identifying such children, what
are the equivalent criteria for adults? If the most severely affected
adults could be identified, would a randomised trial, looking at
outcomes over several years, be appropriate or practicable?
Population
Adults with recurrent tonsillitis.
Intervention
Tonsillectomy or adenotonsillectomy.
Comparison
Usual care, watchful waiting or other medical management.
Outcomes
Episodes of, and number of days with, sore throat and a measure
of their severity, number of days of absence from school or work,
quality of life, complications of surgery, such as haemorrhage, and
number of days with pain postoperatively.
Data should be reported in a way that allows the episode and pain
due to surgery to be taken into account.
Timing
At least one year and preferably two or three years.
There would be little need to consider further studies to evalu-
ate the effectiveness of adeno-/tonsillectomy if three things were
certain. Firstly, that an individual’s throat problems were entirely
due to their tonsils, secondly that these problems were bound to
disappear if they had surgery, and finally that theywould definitely
continue if they did not have surgery. There would certainly be no
need for a randomised trial. Two appropriate research questions
therefore might be:
1. Is it possible to identify those individuals in whom the
presence of the palatine tonsils is a critical determinant of their
clinical condition?
2. Is it possible to better predict which individuals will
continue to have problems and to predict the severity of those
problems?
It is unlikely to be easy, and may not be possible, to address these
uncertainties.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Alho 2007
Methods Allocation: randomised - replacement randomisation
Design: parallel groups, average follow-up about 6 months
Participants Number: 70 adults out of 298 screened
Age: 15 years and above
Setting: ENT Department of the University of Oulu Hospital (Finland)
Eligibility criteria:
• 3 or more episodes of pharyngitis in 6 months or 4 episodes in 12 months
• The signs and symptoms during the episodes had to be typical of streptococcal
pharyngitis. In addition, these episodes had to be severe enough for the patient to seek
medical attention and at least 1 episode had to be group A streptococcal infection
proved by culture or rapid antigen test
Exclusion criteria:
• History of peritonsillar abscess, ongoing antibiotic treatment for other illness,
recurrence probably caused by non-compliance with treatment, major heart or airway
disorder or bleeding diatheses that would make same day surgery unfeasible, and
residence outside the city of Oulu or the neighbouring 8 communities
Interventions Intervention group: tonsillectomy (total extracapsular tonsillectomy using blunt or
diathermy dissection); n = 36
Comparator group: watchful waiting (remaining on waiting list); n = 34
Use of additional interventions: participants in the control group did not receive pro-
phylactic treatment for their tonsillitis. No information was provided on any standard-
ised treatment strategy in case of tonsillitis recurrence during follow-up
Outcomes Primary outcome:
Proportion of patients with an acute episode of group A streptococcal pharyngitis during
the 90 days’ follow-up, as determined by signs and symptoms of acute pharyngitis with
a positive result of throat culture
Secondary outcomes:
• Percentage change in the proportion of patients with all episodes of pharyngitis at
90 days
• The times to episodes during the whole follow-up period
• The difference in the mean rates of episodes during the whole follow-up period
• Days with symptoms (fever, sore throat, rhinitis, cough) during the whole follow-up
period
• All episodes of pharyngitis (an episode was considered to be at least 2 consecutive days
with sore throat)
The mean length of follow-up was 164 (SD 63) in the control group and 170 (SD 12)
in the tonsillectomy group
Patients recorded episodes and days with symptoms in diaries
All participants were advised to visit their own general practitioner if they had acute
symptoms suggestive of pharyngitis. The general practitioner would then take a culture
sample from the pharynx and send it to Oulu University Hospital for analysis. Patients
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Alho 2007 (Continued)
were given written instructions for their general practitioner about the study and how
to obtain the culture sample (from surface of both tonsils or tonsillar fossae in patients
who had undergone tonsillectomy and the posterior pharyngeal wall). The patients were
told that it was important to seek medical advice for their symptoms during the trial
in exactly the same way they had done before the trial and that it was possible to have
streptococcal pharyngitis after tonsillectomy
Funding sources None declared
Declarations of interest None declared
Notes Baseline characteristics were balanced
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quotes: “generated the randomisation se-
quence with a computer random number
generator”. “To avoid disparity between
group sizes, we used replacement randomi-
sation”
Allocation concealment (selection bias) Low risk Quotes: “... concealed from the investi-
gators who enrolled the participants ...
sequentially numbered sealed opaque en-
velopes. These were opened sequentially
only after an eligible participant had been
found and informed consent obtained...”
“This task was performed by research assis-
tant not involved in the assignment of care
to the trial participants”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding. No information about stan-
dardised treatment for sore throats during
follow-up
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding. Outcomes were patient-re-
ported (subjective)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up at 90 days. Patients
analysed according to group randomised
Selective reporting (reporting bias) Unclear risk Insufficient information to permit a judge-
ment of low or high risk
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Alho 2007 (Continued)
Other bias Low risk No other important sources of bias were
found
Proportion of patients who did not re-
ceive assigned treatment:
• Participants in intervention group
who did not have surgery: 0/36 (0%)
• Participants in control group who
had surgical treatment within 90 days: 2/
34 (5%), 1 due to pain, another to
coincide with another sibling undergoing
surgery
Koskenkorva 2013
Methods Allocation: randomised - simple randomisation
Design: parallel groups, average follow-up about 6 months
Participants Number: 86 adults out of 260 screened
Age: 13 years and above
Setting: tertiary care ENT centre in Oulu (Finland)
Eligibility criteria:
• 3 or more episodes of pharyngitis within the previous 12 months
• These episodes had to be disabling, prevent normal functioning, be severe enough
for the patient to seek medical attention and be thought to involve the palatine tonsils
• It was not necessary for culture or antigen tests to have shown infection with
group A Streptococcus
Exclusion criteria:
• History of peritonsillar abscess, chronic tonsillitis, ongoing antibiotic treatment,
residence outside of the Oulu region, pregnancy or previous illness making same-day
surgery unfeasible
Interventions Intervention group: tonsillectomy (total extracapsular tonsillectomy using blunt or
diathermy dissection); n = 46 (45 patients underwent tonsillectomy and 1 patient un-
derwent adenotonsillectomy)
Comparator group: watchful waiting (placement on waiting list for tonsillectomy to
undergo surgery after 5 to 6 months); n = 40
Use of additional interventions: no information was provided on a standardised treat-
ment strategy in cases where there was an acute sore throat/pharyngitis recurrence during
follow-up
Outcomes Primary outcome:
• Proportion of patients who had a severe episode of pharyngitis within 5 months.
A severe episode was defined as acute throat pain and signs suggesting the symptoms
originated in the pharynx (oedema, erythema, exudative tonsillitis, anterior cervical
lymphadenitis), which led to medical consultation. In addition, the serum level of C-
reactive protein had to be higher than 40 mg/L either at the day of the medical
consultation or 3 days later. If a blood sample was not taken, the result of a throat
culture had to show other than normal flora, and the patient had to grade the throat
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Koskenkorva 2013 (Continued)
pain as severe
Secondary outcomes:
• Proportion of patients with any episode of pharyngitis (sore throat lasting at least
2 days) and episodes with medical consultation during the 5-month follow-up
• Times to pharyngitis episodes
• Reported number of sore throat episodes
• Reported number of sore throat days
• Reported number of days absent from school or work
• Reported number of symptomatic days during follow-up
• Health-related quality of life (Glasgow Benefit Inventory) in the intervention
group (Robinson 1996)
• Adverse effects related to tonsillectomy
The patients used a symptom diary to record the presence and severity (mild, moderate
or severe) of throat pain, cough, rhinitis, fever and absence from school or work. Data
concerning acute visits and tonsillectomy were recorded from patients’ charts
Patients were advised to visit the study physician or their general practitioner whenever
they had acute symptoms suggestive of pharyngitis. In addition, they were told that it
was important to seek medical advice for their symptoms during the trial exactly as they
had done before. At the acute visit, patients underwent a clinical examination including
a throat swab and a blood test to measure serum levels of C-reactive protein. The blood
test was repeated 3 days later. All laboratory andmicrobiological analyses were performed
by staff blinded to the clinical data
Funding sources None declared
Declarations of interest None declared
Notes Baseline characteristics were balanced
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “We assigned patients ... using sim-
ple randomisation”
Allocation concealment (selection bias) Low risk Quote: “The allocation sequence was con-
cealed from the investigators using sequen-
tially numbered sealed opaque envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding. No additional information
about management of sore throats
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding. Outcomes were patient-re-
ported (subjective)
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Koskenkorva 2013 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses to follow-up
2 patients, 1 in each group, lost their symp-
tom diaries but reported not having con-
sulted a physician for throat pain.These pa-
tients were assumed to have no symptoms
during the study period
Selective reporting (reporting bias) Unclear risk Insufficient information to permit a judge-
ment of low or high risk
Other bias Low risk No other sources of bias were found
Proportion of patients who did not re-
ceive assigned treatment:
• Participants in intervention group
who did not have surgery: 0/46 (0%)
• Participants in control group who
had surgical treatment within 5 months:
3/40 (8%)
Lock 2010
Methods Allocation: randomised. Stratification for age (3 age groups) and study centre with use
of balanced blocks
Design: parallel groups. 2-year follow-up. Study was done alongside a parallel non-
randomised preference study
Participants Number: 268 children (729 patients enrolled into study out of 1546 screened; the other
children were enrolled into the non-randomised arms of the study)
Age: 4 to 15 years
Setting: 5 secondary care ENT departments located in the north of England or west of
Scotland (UK)
Eligibility criteria:
At the start of the trial (May 2002) the inclusion criteria were:
• children (or carers) reporting experience of mild symptoms, 6 or more episodes
within 2 years or 8 or more episodes within 1 year, or
• children reporting experience of moderate symptoms (sore throat for 5 days or
more), 6 or more episodes within 2 years or 6 or more within 1 year
Mid-way through the study (May 2004), the inclusion criteria were amended to:
• children (or carers) reporting experience of 4 or more episodes of sore throat
within each of 2 years or 6 or more episodes of sore throat within 1 year
Exclusion criteria:
• Previous tonsillectomy, hospitalisation due to tonsillitis, quinsy, marked
obstructive airway during attack
• Comorbidity affecting ability to undergo surgery within 6 months
• Bleeding disorder, otitis media with effusion, sleep apnoea syndrome, rare medical
condition (e.g. glomerulonephritis or Henoch-Schönlein purpura), suspected
velopharyngeal insufficiency, congenital/valvular heart disease
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Interventions Intervention group: tonsillectomy (dissection or bipolar diathermy according to surgical
preference) or adenotonsillectomy (tonsillectomy with adenoid curettage); n = 131
Comparator group: standard non-surgical (medical) treatment; n = 137
Use of additional interventions: the referring general practitioner was free to treat
recurrences of sore throat according to his or her standard practice
Outcomes Primary outcome:
• Reported number of episodes of sore throat in the 2 years after entry into the
study (these data were presented as the mean number of episodes per month in Year 1
and Year 2)
Secondary outcomes:
• Reported number of episodes of sore throat, otitis media and upper respiratory
tract infection that invoked a general practitioner consultation
• Reported severity of sore throats
• Reported number of symptom-free days
• Quality of life (PedsQoL, parent-reported)
• Surgical and anaesthetic morbidity
Data on sore throats were gathered by a simple structured daily health diary, which was
completed and returned by participants on a monthly basis for 24 months (monthly
diaries). In addition, outcome questionnaires were administered to study participants at
3, 12 and 24months into the study.Data on consultation rates and prescribedmedication
were gathered from general practitioner’s medical records by manual abstraction by
trained researchers at the end of follow-up for all trial participants
The study aimed to follow up all participants for 24 months from the date of initial
randomisation; this was not done
Funding sources UK Department of Health through the National Institute of Health Research, Health
Technology Assessment Programme
Declarations of interest None declared
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Independent ... web-based com-
puter randomisation”
Allocation concealment (selection bias) Low risk Quote: “Independent ... web-based com-
puter randomisation”. Blocked randomi-
sation was used; unclear how large these
blocks were
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding. The referring general practi-
tioner was free to treat recurrences of sore
throat according tohis or her standard prac-
tice
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Lock 2010 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote: “... all researchers who conducted
interviews or processed self-completed
questionnaires and diaries were blind to in-
terventions of all ... participants”
Comment: since the content of question-
naires and diaries was based on the re-
ports of participants/carers who were not
blind, it is not clear how effective the de-
scribed strategy would be in reducing de-
tection bias. Furthermore, the main out-
comes, such as number of episodes and
days with sore throat, were estimated based
on patient diaries and were subjective. The
question asked was “Was your child both-
ered by any of the following today?” and
“sore throat” was an option
Incomplete outcome data (attrition bias)
All outcomes
High risk There was a very high risk of bias from the
loss of data and imputations
Significant loss of outcome data because of
the following:
1. Loss of participants (not included in
analyses); the reasons for loss to follow-up
not described
• Participants not included in
analyses at Year 1: 37/268 (14%)
◦ Intervention arm: 12/131 (9%)
◦ Control arm: 25/137 (18%)
• Participants not included in
analyses at Year 2: 111/268 (41%)
◦ Intervention arm: 48/131
(37%)
◦ Control arm: 63/137 (46%)
2. Loss of outcome data from monthly di-
aries (mean number of diaries returned per
participant was 9.91 out of a maximum of
24 (41%) over 2 years)
Data on number of episodes and days with
sore throat were collected through diaries.
Given the loss of participants and outcome
data, it was unclear how the following was
estimated:
• “mean number of episodes of sore
throat per month” at end of Year 1 and
Year 2 (Table 12 of Lock 2010)
• “unadjusted estimate” of “mean
number of sore throats” over 2 years
(Table 16 of Lock 2010)
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Lock 2010 (Continued)
• “mean days of sore throat in Year 1
and Year 2” (Table 17 of Lock 2010)
The number of episodes and days with sore
throat pain over 2 years seemed to be esti-
mated by taking the mean number of sore
throat per (4-week) diary returned multi-
plied by 26. However, the numbers in Ta-
ble 17 of Lock 2010 do not seem to be
completely consistent with the application
of this method
• The average number of diaries
returned per child was 9.91, out of 24 4-
weekly diaries sent (page 11). The
proportion of diaries returned per child
was low (9.91/24 = 41%)
• Imputations were done for missing
data for the non-returned diaries, but the
data could have been missing in a non-
random manner; e.g. patients may be
more likely to return a diary that has been
filled in when they were symptomatic
• The study report noted that there
was a possible overestimation of the
number of episodes and days with sore
throat. When adjusted for the number of
diaries a child returned, the weighted
mean number of sore throats decreased
from 11.4 to 9.0 in the medical group and
7.4 to 5.5 in the surgery group over 2 years
3. Loss of outcome data from question-
naires at 12 and 24 months for quality of
life data
Participants for whom outcome ques-
tionnaire data were available at 12
months - intervention arm:
Year 1 - 73/131 (58%)
Year 2 - 64/131 (49%)
Participants for whom outcome ques-
tionnaire data were available at 12
months - comparator arm:
Year 1 - 55/137 (40%)
Year 2 - 54/137 (39%)
Participants were analysed by group ran-
domised
Selective reporting (reporting bias) Unclear risk Insufficient information to judge whether
low risk or high risk of bias
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Lock 2010 (Continued)
Other bias Unclear risk Subjects were analysed by group ran-
domised (ITT), but one-quarter of patients
in the control arm received surgical inter-
vention
Proportion of patients who did not re-
ceive assigned treatment at the end of 2
years (Year 1 data not available)
• Participants in intervention group
who did not have surgery: 11/131 (8%)
• Participants in control group who
had surgical treatment: 36/137 (26%)
Paradise 1984
Methods Allocation: randomised; stratification for age (3 age groups) with use of balanced blocks
of 4
Design: parallel groups. Study was done alongside a non-randomised cohort study
Participants Number: 91 children randomised out of 2043 patients screened
Age: 3 to 15 years
Setting: Children’s Hospital of Pittsburgh (USA). Participants were recruited among
hospital outpatients, children referred by community practitioners or directly by parents
between August 1971 and June 1982
Eligibility criteria:
• History of recurrent episodes of throat infection (i.e. tonsillitis, pharyngitis or
tonsillopharyngitis)
The episodes had to meet defined standards in each of 4 categories:
(1) Frequency of occurrence: 7 or more episodes in the preceding year, 5 or more in each
of the 2 preceding years, or 3 or more in each of the preceding 3 years
(2) Clinical features: each episode characterised by 1 or more of the following: oral
temperature of at least 38.3 °C, cervical lymphadenopathy (enlarged (> 2 cm) or tender
cervical lymph nodes), tonsillar or pharyngeal exudate, or positive culture for group A
beta-haemolytic Streptococcus
(3) Treatment: antibiotics administered at conventional dosage for proven or suspected
streptococcal episodes
(4) Documentation: each episode and its qualifying features substantiated by concurrent
notation in a medical record
Exclusion criteria:
• Judged to require prompt removal of large tonsils or adenoids because of proven
or suspected alveolar hypoventilation, sustained difficulty in swallowing or marked
discomfort in breathing
• Prior tonsil or adenoid surgery, major physical or emotional disease, structural
middle-ear damage or sensorineural hearing loss, hypogammaglobulinaemia (IgG, IgA
or IgM level > 2 SD below the mean value for the child’s age)
• Simultaneous enrolment of a sibling in the study, or inability to meet the
projected schedule of follow-up visits
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Paradise 1984 (Continued)
Interventions Intervention group 1: tonsillectomy (dissection and snare technique); n = 27
Intervention group 2: adenotonsillectomy (dissection and snare technique for tonsil-
lectomy; reverse adenotomes and curettes for adenotomy); n = 16
Comparator group 1: non-surgical treatment; n = 29
Comparator group 2: non-surgical treatment; n = 19
The trial data were pooled (and not presented separately) in the publication:
Intervention group: tonsillectomy or adenotonsillectomy; n = 43
Comparator group: non-surgical treatment; n = 48
Use of additional interventions: cultures for the presence of group A streptococci in
case of suspected or diagnosed throat infections showing growth of any degree were
considered positive. Penicillin V (250 mg) - or erythromycin (10 mg/kg body weight)
in case of presumed allergy to penicillin - was prescribed 4 times daily for 10 days for all
participants with positive cultures and also for those whose cultures were negative but
who had been treated presumptively from the outset and had improved markedly within
48 hours
Outcomes Primary outcome:
• Observed episodes of throat infections based on 3 criteria:
◦ moderate/severe sore throat;
◦ group A streptococcal infection; or
◦ “counting” method.
Secondary outcomes:
• Proportion of visits with isolated cervical lymphadenopathy
• Number of parent-reported sore throat days
• Number of days of sore throat-associated school absence
A standardised telephone or in-person inquiry was made bi-weekly concerning the day-
by-day occurrence of specified symptoms and events, including sore throat and absence
from school. Standardised clinical examinations were performed at 6-week intervals and
at the time of respiratory illnesses
Funding sources ER McCluskey Memorial Research. Programme fund from the Children’s Hospital in
Pittsburgh and National Institute of Child Health and Human Development
Declarations of interest None declared
Notes Not balanced for history of episodes of throat infection before trial entry and parental
socioeconomic status (2 of 11 comparisons): 65% in the control group were skilled
workers or executives/professionals, whereas 65% in the surgery group were of semi-
skilled/unskilledworkers or disabled/unemployed/receivingpublic assistance/other. 47%
in the surgery group had more than 7 infections within the past year, whereas only 23%
in the control group met this criterion. 67% in the control group met the criterion of
>= 3 infections per year over the past 3 years
Risk of bias
Bias Authors’ judgement Support for judgement
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Paradise 1984 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “assigned randomly, within cate-
gories and balanced blocks of four”
Allocation concealment (selection bias) Unclear risk Comment: not described. Small block size
(4 participants) potentially allows prior
knowledge of allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding. However, there was a clear
protocol for management of reported sore
throats
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding. Patients were followed up bi-
weekly by either a standardised telephone
or in-person inquiry. Patients reported their
symptoms
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: significant number of patients
not included in analyses especially in years
2 and 3. Patients were excluded from analy-
sis for these reasons 1) loss to follow-up; 2)
not treated as randomised (patients in the
control arm who received surgery were ex-
cluded from analysis); 3) did not complete
the full follow-up periods in the analysis
Proportionof patients not included in anal-
ysis is higher in the control groups
Children electing for surgery in the control
group
Participants not included in analyses to-
tal:
Year 1 - 18/91 (20%)
◦ Intervention arm: 5/43 (12%)
◦ Control arm: 13/48 (27%)
Year 2 - 31/91 (34%)
◦ Intervention arm: 12/43 (28%)
◦ Control arm: 19/48 (40%)
Year 3 - 49/91 (54%)
◦ Intervention arm: 21/43 (49%)
◦ Control arm: 28/48 (58%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit a judge-
ment of low or high risk
Other bias Unclear risk Proportion of patients who did not re-
ceive assigned treatment:
• Participants in intervention group
who did not have surgery within 90 days:
8/43 (19%)
• Participants in control group who
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Paradise 1984 (Continued)
had surgical treatment (cumulative
numbers)
◦ Year 1 = 7/48 (15%)
◦ Year 2 = 12/48 (25%)
◦ Year 3 = 16/48 (33%)
Baseline characteristics: not balanced for
history of episodes of throat infection be-
fore trial entry and parental socioeconomic
status (2 of 11 comparisons)
Paradise 2002a
Methods Allocation: randomised; stratification for age (3 age groups) and history (whether the
frequency or clinical features of previous historymet the eligibility criteria for the Paradise
1984 trial) with use of balanced blocks of 3
Design: parallel groups, 3-armed trial. Study was done alongside a 2-arm study (see
Paradise 2002b)
Participants Number: 177 children (373 patients were eligible for either of the studies, Paradise
2002a or Paradise 2002b, from 2174 patients screened)
Age: 3 to 15 years
Setting: Children’s Hospital of Pittsburgh (USA). Participants were recruited among
hospital outpatients, children referred by community practitioners or directly by parents
between April 1982 to March 1994
Eligibility criteria:
• History of recurrent episodes of throat infection (i.e. tonsillitis, pharyngitis or
tonsillopharyngitis). The episodes had to meet slightly less stringently defined
standards regarding either the frequency of previous episodes or their clinical features
or their degree of documentation than those used in the Paradise 1984 trial. Details are
described in full in the appendix of the publication, but in summary these include:
• ◦ Aged 3 to 15 years: 7 or more counting episodes in the preceding year, 5 or
more counting episodes in each of the 2 preceding years, or 3 or more counting
episodes in each of the preceding 3 years. If all previous episodes were undocumented,
1 qualifying unit observed by a study team clinician within 4 months after initial
observation. If previous episodes were partially documented, notation in a clinical
record indicating the occurrence of 1 qualifying unit within the 3 months period
preceding initial evaluation
◦ Aged 3 to 6 years: 5 or 6 qualifying units in the preceding year, including at
least 2 counting episodes or 4 qualifying units in each of the past 2 years including at
least 2 counting episodes in each year
◦ Aged 7 to 15 years: 4 to 6 qualifying units in the preceding year, including at
least 1 counting episode or 3 qualifying units in each of the past 2 years including at
least 1 counting episode in each year
• No apparent indications for adenoidectomy (obstructing adenoids or history of
recurrent or persistent otitis media)
Exclusion criteria:
• Children judged to require prompt removal of large tonsils or adenoids because of
obstructive symptoms
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Paradise 2002a (Continued)
• Children who met the eligibility criteria for the earlier tonsillectomy trials
(Paradise 1984)
Interventions Intervention group 1: tonsillectomy (dissection and snare technique); n = 58
Intervention group 2: adenotonsillectomy (dissection and snare technique for tonsil-
lectomy; reverse adenotomes and curettes for adenotomy); n = 59
Comparator group: non-surgical treatment; n = 60
Use of additional interventions: cultures for the presence of group A Streptococcus in
case of suspected or diagnosed throat infections showing growth of any degree were
considered positive. Penicillin V (250 mg) - or erythromycin (10 mg/kg body weight)
in case of presumed allergy to penicillin - was prescribed 4 times daily for 10 days for all
patients with positive cultures and also for those whose cultures were negative but who
had been treated presumptively from the outset and had improved markedly within 48
hours
Outcomes Primary outcome:
• Observed episodes of throat infections based on 3 criteria:
◦ moderate/severe sore throat;
◦ group A streptococcal infection; or
◦ “counting” method.
Secondary outcomes:
• Proportion of visits with isolated cervical lymphadenopathy
• Number of parent-reported sore throat days
• Number of days of sore throat-associated school absence
A standardised telephone or in-person inquiry was made bi-weekly concerning the day-
by-day occurrence of specified symptoms and events, including sore throat and absence
from school. Standardised clinical examinations were performed at 6-week intervals and
at the time of respiratory illnesses
Funding sources National Institute of Child Health and Human Development. The Children’s Hospital
of Pittsburgh waived insurance charges and professional fees for patients who lacked
insurance coverage
Declarations of interest None declared
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “... using computer generated ran-
dom number lists”
Allocation concealment (selection bias) Unclear risk Quote: “Assignments were made by desig-
nated non-clinical staffmembers using sep-
arate, computer generated random number
lists”
Small block size (3 participants) potentially
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Paradise 2002a (Continued)
allows prior knowledge of allocation. There
was no blinding and it was unclear whether
the person(s) making the decisions about
enrolment were aware of the preceding al-
locations
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding. However, there was a clear
protocol for management of sore throat
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding. Outcomes were patient-re-
ported (subjective)
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: a significant number of partici-
pants were not included in analyses due to
loss to follow-up, especially in years 2 and
3
Participants not included in analyses to-
tal:
Year 1 - 30/177 (17%)
◦ Intervention group 1: 11/58
(19%)
◦ Intervention group 2: 13/59
(22%)
◦ Control group: 6/60 (10%)
Year 2 - 53/177 (30%)
◦ Intervention group 1: 17/58
(29%)
◦ Intervention group 2: 23/59
(39%)
◦ Control group: 13/60 (22%)
Year 3 - 73/177 (41%)
◦ Intervention group 1: 22/58
(38%)
◦ Intervention group 2: 31/59
(53%)
◦ Control group: 20/60 (33%)
Reasons for loss to follow-up not described,
and it was unclear if those lost to follow-
up were also patients who did not receive
intervention as randomised
Subjects were analysed based on the groups
randomised (ITT analysis). No data impu-
tation for loss to follow-up
Selective reporting (reporting bias) Unclear risk Insufficient information to permit a judge-
ment of low or high risk
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Paradise 2002a (Continued)
Other bias Low risk Proportion of patients who did not re-
ceive assigned treatment:
• Participants in intervention group 1
who did not have surgery: 5/58 (9%)
• Participants in intervention group 2
who did not have surgery: 5/59 (8%)
• Participants in control group who
had surgical treatment (cumulative
numbers)
◦ Year 1 - 5/60 (8%)
◦ Year 2 - 7/60 (12%)
◦ Year 3 - 12/60 (20%)
Baseline characteristics: balanced
Paradise 2002b
Methods Allocation: randomised; stratification for age (3 age groups) and history (whether the
frequency or clinical features of previous historymet the eligibility criteria for the Paradise
1984 trial) in balanced blocks of 4
Design: parallel-group. This studywas done alongside a 3-arm study (see Paradise 2002a)
Participants Number: 151 children (373 patients were eligible for either of the study, Paradise 2002a
or Paradise 2002b from 2174 patients screened)
Age: 3 to 15 years
Setting: Children’s Hospital of Pittsburgh (USA). Participants were recruited among
hospital outpatients, children referred by community practitioners or directly by parents
between April 1982 to March 1994
Eligibility criteria:
• History of recurrent episodes of throat infection (i.e. tonsillitis, pharyngitis or
tonsillopharyngitis). The episodes had to meet slightly less stringently defined
standards regarding either the frequency of previous episodes or their clinical features
or their degree of documentation than those used in the Paradise 1984 trial. Details are
described in full in the appendix of the publication, but in summary these include:
• ◦ Aged 3 to 15 years: 7 of more counting episodes in the preceding year, 5 or
more counting episodes in each of the 2 preceding years, or 3 or more counting
episodes in each of the preceding 3 years. If all previous episodes were undocumented,
1 qualifying unit observed by a study team clinician within 4 months after initial
observation. If previous episodes were partially documented, notation in a clinical
record indicating the occurrence of 1 qualifying unit within the 3 months period
preceding initial evaluation
◦ Aged 3 to 6 years: 5 or 6 qualifying units in the preceding year, including at
least 2 counting episodes or 4 qualifying units in each of the past 2 years including at
least 2 counting episodes in each year
◦ Aged 7 to 15 years: 4 to 6 qualifying units in the preceding year, including at
least 1 counting episodes or 3 qualifying units in each of the past 2 years including at
least 1 counting episodes in each year
• One or more indications for adenoidectomy (obstructing adenoids or histories of
recurrent or persistent otitis media)
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Paradise 2002b (Continued)
Exclusion criteria:
• Children judged to require prompt removal of large tonsils or adenoids because of
obstructive symptoms
• Children who met the eligibility criteria for the earlier tonsillectomy trial
(Paradise 1984)
Interventions Intervention group: adenotonsillectomy (dissection and snare technique for tonsillec-
tomy; reverse adenotomes and curettes for adenotomy); n = 73
Comparator group: non-surgical treatment; n = 78
Use of additional interventions: cultures for the presence of group A Streptococcus in
case of suspected or diagnosed throat infections showing growth of any degree were
considered positive. Penicillin V (250 mg) - or erythromycin (10 mg/kg body weight)
in case of presumed allergy to penicillin - was prescribed 4 times daily for 10 days for all
patients with positive cultures and also for those whose cultures were negative but who
had been treated presumptively from the outset and had improved markedly within 48
hours
Outcomes As in Paradise 2002a
Funding sources National Institute of Child Health and Human Development. The Children’s Hospital
of Pittsburgh waived insurance charges and professional fees for patients who lacked
insurance coverage
Declarations of interest None declared
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “... using computer generated ran-
dom number lists”
Allocation concealment (selection bias) Unclear risk Quote: “Assignments were made by desig-
nated non-clinical staffmembers using sep-
arate, computer generated random number
lists.”
Small block size (4 participants) potentially
allows prior knowledge of allocation. There
was no blinding and it was unclear whether
the person(s) making the decisions about
enrolment were aware of the preceding al-
locations
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding. However, there was a clear
protocol for the management of sore
throats
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Paradise 2002b (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding. Outcomes were patient-re-
ported (subjective)
Incomplete outcome data (attrition bias)
All outcomes
High risk Significant number of participants not in-
cluded in analyses due to loss to follow-up
Participants not included in analyses to-
tal:
• Year 1 - 25/151 (17%)
• ◦ Intervention group: 14/73
(19%)
◦ Control group: 11/78 (14%)
• Year 2 - 39/151 (26%)
◦ Intervention group: 23/73
(32%)
◦ Control group: 16/78 (21%)
• Year 3 - 53/151 (35%)
◦ Intervention group: 29/73
(40%)
◦ Control group: 23/78 (29%)
Reasons for loss to follow-up not described
and it was unclear if those lost to follow-up
were also patients who did not receive the
intervention as randomised
Participants were analysed based on the
groups randomised (ITT analysis). No data
imputation for loss to follow-up
Selective reporting (reporting bias) Unclear risk Insufficient information to permit a judge-
ment of low or high risk
Other bias Low risk Proportion of patients who did not re-
ceive assigned treatment:
• Participants in intervention group 1
who did not have surgery: 8/73 (11%)
• Participants in control group who
had surgical treatment (cumulative
numbers)
◦ Year 1 - 12/78 (15%)
◦ Year 2 - 17/78 (22%)
◦ Year 3 - 19/78 (24%)
Baseline characteristics: balanced
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Stafford 1986
Methods Allocation: randomised
Design: prospective, parallel
Participants Number: 40
Age: range 16 to 42 years
Setting: ENT outpatient department of tertiary centre in London. Patients were referred
by general practitioners
Male/female: 3/17 in surgery group, 6/14 in antibiotic group
Average number of tonsillitis episodes per year: 6 in tonsillectomy, 5 in antibiotics group
Eligibility criteria:
• 16 years or older
• A history of at least 4 episodes of tonsillitis per year for at least 2 years; each
episode consisting of sore throat, dysphagia, pyrexia and general malaise, and lasting a
minimum of 3 days
• Normal full blood count and negative Paul Bunnell test
Interventions Intervention group: tonsillectomy; n = 20
Comparator group: antibiotics, n = 20
Penicillin V 250 mg, 4 times per day for 8 days for each episode of tonsillitis for the
following year
Patients with penicillin allergy are given either co-trimoxazole “2 tablets” 2 times daily
or erythromycin 250 mg 4 times per day
Use of additional interventions: none described
Outcomes Time point of measure unclear, most likely between 18 months to 2 years
• “Cure rate” as reported by patients
Patients in the surgery group were reviewed at 6, 12 and 18 months postoperatively
Patients in the antibiotics group were reviewed every 3 months in outpatients. GPs were
sent questionnaires to complete and return each time a patient was seen and prescribed
an antibiotic for tonsillitis
Funding sources No information provided
Declarations of interest No information provided
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “randomly allocated”
No description of allocation concealment
method
Allocation concealment (selection bias) Unclear risk No description of allocation concealment
method
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Stafford 1986 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No blinding. Patients, investigators and
general practitioners in charge of follow-up
of both groups were aware of treatment al-
location
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Comment: no blinding. Outcomes were
patient-reported (whether patients “felt
cured” of symptoms)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All patients analysed
Selective reporting (reporting bias) Unclear risk No access to protocol. Insufficient infor-
mation to judge
Other bias High risk Follow-up frequency and setting were dif-
ferent between groups. Method of eliciting
results most likely different. 6/20 patients
in the control arm had received tonsillec-
tomy within 2 years
van Staaij 2004
Methods Allocation: randomised; computer-generated random list of 4 numbers in each block
and fixed blocks within each hospital
Design: parallel-group. Patients were followed up to 2 years, or the end of the trial,
whichever was earlier
Participants Number: 300 children out of 1226 screened
Age: 2 to 8 years
Setting: ENT surgeons from 21 general hospitals and 3 academic centres in The Nether-
lands
Eligibility criteria:
• Adenotonsillectomy indicated according to “current medical practice” in the
Netherlands. ENT surgeons were asked to provide the indication they considered most
important for surgery: recurrent throat infections (3 or more a year) or other
indications such as obstructive problems or recurrent upper respiratory tract infections
Exclusion criteria:
• Children meeting strict Paradise 1984 criteria
• Children with suspected obstructive sleep apnoea
• Down’s syndrome, craniofacial malformations such as cleft palate, and
immunodeficiency other than deficiencies of IgA or IgG
Interventions Intervention group: adenotonsillectomy; n = 151
Comparator group: watchful waiting; n = 149
Use of additional interventions: the parents, general practitioners and ENT surgeons
were encouraged to manage sore throats and upper respiratory tract infections during
follow-up in line with their regular practice
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van Staaij 2004 (Continued)
Outcomes Primary outcome:
• Incidence of fever (a temperature of 38.0 °C or higher) for at least 1 day
Secondary outcomes:
• Throat infections
• Sore throat
• Upper respiratory tract infection
• Absence from day-care or school due to upper respiratory tract infection
• Health-related quality of life
• Patterns of sleep and eating
• Height and weight.
Note: authors were contacted to obtain 1-year data
The parents kept a diary of upper respiratory tract infections in their child, which
included sore throat, pain or difficulty in swallowing, cough, rhinorrhoea, earache and
otorrhoea and absences from day-care or school due to upper respiratory tract infections.
Parents measured the child’s temperature daily with a validated tympanic membrane
thermometer
During scheduled follow-up visits at 3, 6, 12, 18 and 24 months, health-related quality
of life questionnaires were completed and ENT examination was carried out
Funding sources Dutch Healthcare Insurance Board
Declarations of interest None declared
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomisation was by a computer
generated list of 4 numbers in each block
and fixed blocks within each hospital”
Allocation concealment (selection bias) Unclear risk Comment: not described. Small block size
(4 participants) potentially allows prior
knowledge of allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Noblinding.No further information about
management of sore throats
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Although the primary outcome measure of
the study was “fever”, measured objectively
and with the results stored automatically,
the outcomes of interest in this review may
have been subject to detection bias
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van Staaij 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The study was completed at a fixed time
point (February 2003), and the length of
follow-up for patients varied, depending on
the time of recruitment
Loss to follow-up relatively low:
Participants not included in analyses to-
tal: 43/300 (14%); reasons for loss to fol-
low-up described
Participants not included in analyses -
intervention group: 18/151 (12%)
Participants not included in analyses -
comparator group: 25/149 (17%)
The amount of data available for each time
point was the following (data from authors)
:
For 12 months (denominator indicated the
potential number of patients available; i.e.
who could have completed the follow-up
for the length of time):
• Total number of children available in
analysis: 262
• Number of children allocated to
ATE and completed 12 months: 111/131
(84.7%)
• Number of children allocated to
WW and completed 12 months: 107/131
(81.7%)
For 23 months:
• Total number of children available in
analysis: 174
• Number of children allocated to
ATE and completed 24 months: 70/88
(79.5%)
• Number of children allocated to
WW and completed 24 months: 69/86
(80.2%)
For 24 months:
• Total number of children available in
analysis: 166
• Number of children allocated to
ATE and completed 24 months: 42/83
(50.6%)
• Number of children allocated to
WW and completed 24 months: 38/83
(45.8%)
Selective reporting (reporting bias) Unclear risk Insufficient information to permit a judge-
ment of low or high risk
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van Staaij 2004 (Continued)
Other bias Low risk Proportion of patients who did not re-
ceive assigned treatment:
• Participants in intervention group
who did not receive surgery: 7/151 (5%)
• Participants in comparator group
who received surgical treatment: 50/149
(34%)
Baseline characteristics - balanced
ATE: adenotonsillectomy
ITT: intention-to-treat
SD: standard deviation
WW: watchful waiting
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Clayburgh 2011 Allocation: non-randomised, prospective cohort study
Kaiser 1930 Allocation: non-randomised, retrospective cohort study
Mawson 1967 Participants: recurrent adenitis alone considered an indication for inclusion; some participants had no attacks
in year prior to trial or number was unknown (Mawson 1967, Table VI)
McKee 1963 Allocation: randomised using hospital number; quasi-randomisation
Participants: children (< 15 years) with throat infections or “acute upper respiratory infections with cervical
adenitis”
Naibo lu 2010 Allocation: non-randomised, prospective cohort study
Roydhouse 1970 Allocation: “Selection of cases [as] described by McKee” (randomised using hospital number); quasi-randomisa-
tion
Participants: children (2 to 13 years) with “recurrent ... tonsillitis and other respiratory tract infections”
Stalfors 2012 Allocation: non-randomised, prospective cohort study
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Characteristics of ongoing studies [ordered by study ID]
NATTINA 2014
Trial name or title The NAtional Trial of Tonsillectomy IN Adults (NATTINA): a clinical and cost effectiveness study
Methods A mixed methods study incorporating a feasibility study, internal pilot and a phase III, multicentre trial ran-
domising patients to immediate tonsillectomy versus conservative management. Patients will be randomised
on a 1:1 basis
Participants Adults (16 years +) referred to secondary care because of disabling recurrent sore throats
Interventions Intervention: immediate tonsillectomy - dissection of the palatine tonsils
Comparison: conservative management, i.e. deferred surgery
Outcomes Primary outcomes:
1. Total number of sore throat days over the 24 months following randomisation
Secondary outcomes:
1. Outcomes measured using NATTINA Sore Throat Alert Reports (STARs) over 24 months
i) Number of sore throats in the category (a) mild or (b) moderate/severe
ii) Use of over-the-counter medication
iii) Use of any prescription therapies
iv) Number of days unable to undertake usual activities
v) SF-12 general health questionnaire referring to the episode
2. Tonsil Outcome Inventory 14 (TOI14) total and subscales (throat, general health, resources and
social/psychological) 6-monthly
3. SF-12 general health questionnaire 6-monthly
4. Nature of any adverse events experienced
5. Evaluation of the impact of alternative sore throat patient pathways by observation and statistical
modelling of outcomes against baseline severity, as assessed by total number of sore throat days recalled in
the 6 months prior to recruitment plus TOI14 score at recruitment.
6. Economic evaluation has 3 components (1) a cost-effectiveness analysis, based on the incremental cost
per sore throat day avoided (2) cost-utility analysis, based on incremental cost per quality-adjusted life year
(QALY) gained (3) cost-benefit analysis, based on patients willingness to pay to avoid a sore throat day
Starting date April 2014. Expected publication July 2019
Contact information Chief investigator: Prof Janet Wilson
Trial manager: Isabel Rubie (isabel.rubie@ncl.ac.uk) (+44) 0191 2087252
Notes Details from HTA website: http://www.nets.nihr.ac.uk/projects/hta/1214606
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D A T A A N D A N A L Y S E S
Comparison 1. Tonsillectomy or adenotonsillectomy versus no surgery in children
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Episodes of sore throat of
any severity (including as
one episode the period
post-surgery) at 12 months
5 795 Mean Difference (IV, Random, 95% CI) -0.56 [-1.04, -0.07]
1.1 Paediatric patients -
severely affected patients
1 73 Mean Difference (IV, Random, 95% CI) -0.90 [-1.92, 0.12]
1.2 Paediatric patients -
moderately affected patients
4 722 Mean Difference (IV, Random, 95% CI) -0.51 [-1.07, 0.05]
2 Episodes of moderate/severe sore
throat (including as one episode
the period post-surgery) at 12
months
4 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Paediatric patients -
severely affected patients
1 73 Mean Difference (IV, Random, 95% CI) -0.09 [-0.57, 0.39]
2.2 Paediatric patients -
moderately affected patients
3 491 Mean Difference (IV, Random, 95% CI) 0.82 [0.70, 0.94]
3 Sore throat days (including those
immediately post-surgery) at
12 months
5 776 Mean Difference (IV, Fixed, 95% CI) -5.13 [-8.06, -2.20]
3.1 Paediatric patients -
severely affected patients
1 64 Mean Difference (IV, Fixed, 95% CI) -2.60 [-9.68, 4.48]
3.2 Paediatric patients -
moderately affected patients
4 712 Mean Difference (IV, Fixed, 95% CI) -5.65 [-8.87, -2.43]
4 Absence from school or work at
12 months
3 316 Mean Difference (IV, Fixed, 95% CI) -2.33 [-3.42, -1.24]
Comparison 2. Tonsillectomy or adenotonsillectomy versus no surgery in adults
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Episodes of sore throat of
any severity (not including
as one episode the period
post-surgery) at 6 months
2 156 Mean Difference (IV, Random, 95% CI) -3.61 [-7.92, 0.70]
2 Sore throat days (not
including those immediately
post-surgery) at 6 months
2 156 Mean Difference (IV, Fixed, 95% CI) -10.64 [-15.52, -5.
76]
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3 Absence from school or work at
6 months
1 96 Mean Difference (IV, Fixed, 95% CI) -3.3 [-7.66, 1.06]
Comparison 3. Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy versus no surgery) in
children
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Episodes of sore throat of
any severity (not including
as one episode the period
post-surgery)
5 795 Mean Difference (IV, Random, 95% CI) -0.44 [-0.88, 0.00]
1.1 Adenotonsillectomy 3 417 Mean Difference (IV, Random, 95% CI) -0.40 [-0.88, 0.07]
1.2 Tonsillectomy 1 74 Mean Difference (IV, Random, 95% CI) 0.18 [-0.53, 0.89]
1.3 Mixed 2 304 Mean Difference (IV, Random, 95% CI) -1.13 [-1.96, -0.31]
2 Episodes of moderate/severe
sore throat (not including
as one episode the period
post-surgery)
4 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Adenotonsillectomy 3 445 Mean Difference (IV, Fixed, 95% CI) 0.84 [0.72, 0.96]
2.2 Tonsillectomy 1 73 Mean Difference (IV, Fixed, 95% CI) 0.85 [0.65, 1.05]
2.3 Mixed 1 146 Mean Difference (IV, Fixed, 95% CI) -0.59 [-0.93, -0.25]
3 Sore throat days (including those
immediately post-surgery)
5 871 Mean Difference (IV, Fixed, 95% CI) -5.14 [-8.03, -2.24]
3.1 Adenotonsillectomy 3 468 Mean Difference (IV, Fixed, 95% CI) -4.51 [-8.09, -0.93]
3.2 Tonsillectomy 1 122 Mean Difference (IV, Fixed, 95% CI) -5.5 [-13.94, 2.94]
3.3 Mixed 2 281 Mean Difference (IV, Fixed, 95% CI) -6.75 [-12.81, -0.69]
Comparison 4. Sensitivity analysis: tonsillectomy or adenotonsillectomy versus no surgery in children - removing
Lock 2010
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Episodes of sore throat of
any severity (including as
one episode the period
post-surgery) at 12 months
4 564 Mean Difference (IV, Random, 95% CI) -0.42 [-0.87, 0.02]
1.1 Paediatric patients -
severely affected patients
1 73 Mean Difference (IV, Random, 95% CI) -0.85 [-1.87, 0.17]
1.2 Paediatric patients -
moderately affected patients
3 491 Mean Difference (IV, Random, 95% CI) -0.36 [-0.86, 0.15]
2 Sore throat days (including those
immediately post-surgery) at
12 months
4 559 Mean Difference (IV, Fixed, 95% CI) -4.26 [-7.29, -1.23]
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2.1 Paediatric patients -
severely affected patients
1 64 Mean Difference (IV, Fixed, 95% CI) -2.60 [-9.68, 4.48]
2.2 Paediatric patients -
moderately affected patients
3 495 Mean Difference (IV, Fixed, 95% CI) -4.63 [-7.98, -1.28]
Analysis 1.1. Comparison 1 Tonsillectomy or adenotonsillectomy versus no surgery in children, Outcome 1
Episodes of sore throat of any severity (including as one episode the period post-surgery) at 12 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 1 Tonsillectomy or adenotonsillectomy versus no surgery in children
Outcome: 1 Episodes of sore throat of any severity (including as one episode the period post-surgery) at 12 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD)[Episodes] N Mean(SD)[Episodes] IV,Random,95% CI IV,Random,95% CI
1 Paediatric patients - severely affected patients
Paradise 1984 38 2.2 (1.62) 35 3.1 (2.64) 14.4 % -0.90 [ -1.92, 0.12 ]
Subtotal (95% CI) 38 35 14.4 % -0.90 [ -1.92, 0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.74 (P = 0.082)
2 Paediatric patients - moderately affected patients
Lock 2010 (1) 119 6 (5.16) 112 7.7 (5.88) 8.9 % -1.70 [ -3.13, -0.27 ]
Paradise 2002a 93 2.91 (1.39) 54 2.78 (1.66) 26.4 % 0.13 [ -0.40, 0.66 ]
Paradise 2002b 59 2.9 (1.37) 67 3.6 (1.87) 25.1 % -0.70 [ -1.27, -0.13 ]
van Staaij 2004 111 2.74 (1.76) 107 3.27 (2.42) 25.2 % -0.53 [ -1.09, 0.03 ]
Subtotal (95% CI) 382 340 85.6 % -0.51 [ -1.07, 0.05 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 8.36, df = 3 (P = 0.04); I2 =64%
Test for overall effect: Z = 1.79 (P = 0.074)
Total (95% CI) 420 375 100.0 % -0.56 [ -1.04, -0.07 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 9.20, df = 4 (P = 0.06); I2 =57%
Test for overall effect: Z = 2.24 (P = 0.025)
Test for subgroup differences: Chi2 = 0.44, df = 1 (P = 0.51), I2 =0.0%
-4 -2 0 2 4
Favours surgery Favours no surgery
(1) Lock 2010 has high risk of attrition bias due to the low rates of return of diaries. However, inclusion of data from this analysis did not affect effect sizes ( see analysis
4.1).
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Analysis 1.2. Comparison 1 Tonsillectomy or adenotonsillectomy versus no surgery in children, Outcome 2
Episodes of moderate/severe sore throat (including as one episode the period post-surgery) at 12 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 1 Tonsillectomy or adenotonsillectomy versus no surgery in children
Outcome: 2 Episodes of moderate/severe sore throat (including as one episode the period post-surgery) at 12 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD)[Episodes] N Mean(SD)[Episodes] IV,Random,95% CI IV,Random,95% CI
1 Paediatric patients - severely affected patients
Paradise 1984 38 1.08 (0.27) 35 1.17 (1.42) 100.0 % -0.09 [ -0.57, 0.39 ]
Subtotal (95% CI) 38 35 100.0 % -0.09 [ -0.57, 0.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.37 (P = 0.71)
2 Paediatric patients - moderately affected patients
Paradise 2002a 93 1.13 (0.41) 54 0.24 (0.51) 55.7 % 0.89 [ 0.73, 1.05 ]
Paradise 2002b 59 1.15 (0.42) 67 0.43 (0.67) 38.1 % 0.72 [ 0.53, 0.91 ]
van Staaij 2004 111 1.69 (0.91) 107 0.86 (2.34) 6.3 % 0.83 [ 0.36, 1.30 ]
Subtotal (95% CI) 263 228 100.0 % 0.82 [ 0.70, 0.94 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.77, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 13.53 (P < 0.00001)
Test for subgroup differences: Chi2 = 13.14, df = 1 (P = 0.00), I2 =92%
-4 -2 0 2 4
Favours surgery Favours no surgery
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Analysis 1.3. Comparison 1 Tonsillectomy or adenotonsillectomy versus no surgery in children, Outcome 3
Sore throat days (including those immediately post-surgery) at 12 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 1 Tonsillectomy or adenotonsillectomy versus no surgery in children
Outcome: 3 Sore throat days (including those immediately post-surgery) at 12 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD)[Days] N Mean(SD)[Days] IV,Fixed,95% CI IV,Fixed,95% CI
1 Paediatric patients - severely affected patients
Paradise 1984 31 16.3 (14.3) 33 18.9 (14.6) 17.1 % -2.60 [ -9.68, 4.48 ]
Subtotal (95% CI) 31 33 17.1 % -2.60 [ -9.68, 4.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
2 Paediatric patients - moderately affected patients
Lock 2010 (1) 110 31 (29.25) 107 49.1 (54.62) 6.3 % -18.10 [ -29.80, -6.40 ]
Paradise 2002a 95 19.5 (14.5) 54 25 (21) 21.5 % -5.50 [ -11.81, 0.81 ]
Paradise 2002b 60 23 (20) 68 24 (17) 20.5 % -1.00 [ -7.48, 5.48 ]
van Staaij 2004 111 12.68 (9.5) 107 18.92 (24.59) 34.6 % -6.24 [ -11.22, -1.26 ]
Subtotal (95% CI) 376 336 82.9 % -5.65 [ -8.87, -2.43 ]
Heterogeneity: Chi2 = 6.38, df = 3 (P = 0.09); I2 =53%
Test for overall effect: Z = 3.44 (P = 0.00058)
Total (95% CI) 407 369 100.0 % -5.13 [ -8.06, -2.20 ]
Heterogeneity: Chi2 = 6.97, df = 4 (P = 0.14); I2 =43%
Test for overall effect: Z = 3.43 (P = 0.00061)
Test for subgroup differences: Chi2 = 0.59, df = 1 (P = 0.44), I2 =0.0%
-20 -10 0 10 20
Favours surgery Favours no surgery
(1) Lock 2010 has high risk of attrition bias due to the low rates of return of diaries. Sensitivity analysis (analysis 4.3) showed that mean difference was reduced by about
1 day, and I2=0 ( no statistical heterogeneity).
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Analysis 1.4. Comparison 1 Tonsillectomy or adenotonsillectomy versus no surgery in children, Outcome 4
Absence from school or work at 12 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 1 Tonsillectomy or adenotonsillectomy versus no surgery in children
Outcome: 4 Absence from school or work at 12 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD)[Absences] N Mean(SD)[Absences] IV,Fixed,95% CI IV,Fixed,95% CI
Paradise 1984 29 3.5 (4.2) 41 6.3 (6.7) 18.2 % -2.80 [ -5.36, -0.24 ]
Paradise 2002a 86 3.6 (3.8) 50 5.3 (4.7) 50.9 % -1.70 [ -3.23, -0.17 ]
Paradise 2002b 52 3.5 (4.2) 58 6.6 (6.2) 30.9 % -3.10 [ -5.06, -1.14 ]
Total (95% CI) 167 149 100.0 % -2.33 [ -3.42, -1.24 ]
Heterogeneity: Chi2 = 1.37, df = 2 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 4.19 (P = 0.000028)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours surgery Favours no surgery
Analysis 2.1. Comparison 2 Tonsillectomy or adenotonsillectomy versus no surgery in adults, Outcome 1
Episodes of sore throat of any severity (not including as one episode the period post-surgery) at 6 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 2 Tonsillectomy or adenotonsillectomy versus no surgery in adults
Outcome: 1 Episodes of sore throat of any severity (not including as one episode the period post-surgery) at 6 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Alho 2007 36 0.6 (0.9) 34 2.1 (2.3) 52.0 % -1.50 [ -2.33, -0.67 ]
Koskenkorva 2013 46 1.5 (2.4) 40 7.4 (5.8) 48.0 % -5.90 [ -7.83, -3.97 ]
Total (95% CI) 82 74 100.0 % -3.61 [ -7.92, 0.70 ]
Heterogeneity: Tau2 = 9.11; Chi2 = 16.92, df = 1 (P = 0.00004); I2 =94%
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours surgery Favours no surgery
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Analysis 2.2. Comparison 2 Tonsillectomy or adenotonsillectomy versus no surgery in adults, Outcome 2
Sore throat days (not including those immediately post-surgery) at 6 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 2 Tonsillectomy or adenotonsillectomy versus no surgery in adults
Outcome: 2 Sore throat days (not including those immediately post-surgery) at 6 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Alho 2007 36 3.2 (5.3) 34 12.1 (14.1) 93.4 % -8.90 [ -13.95, -3.85 ]
Koskenkorva 2013 (1) 46 5.1 (8.7) 40 40.2 (60.5) 6.6 % -35.10 [ -54.02, -16.18 ]
Total (95% CI) 82 74 100.0 % -10.64 [ -15.52, -5.76 ]
Heterogeneity: Chi2 = 6.88, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 4.28 (P = 0.000019)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours surgery Favours no surgery
(1) There was a potential for skewed data as standard deviations larger than means were observed.
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Analysis 2.3. Comparison 2 Tonsillectomy or adenotonsillectomy versus no surgery in adults, Outcome 3
Absence from school or work at 6 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 2 Tonsillectomy or adenotonsillectomy versus no surgery in adults
Outcome: 3 Absence from school or work at 6 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Koskenkorva 2013 46 3.3 (10) 50 6.6 (11.8) 100.0 % -3.30 [ -7.66, 1.06 ]
Total (95% CI) 46 50 100.0 % -3.30 [ -7.66, 1.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy
versus no surgery) in children, Outcome 1 Episodes of sore throat of any severity (not including as one episode
the period post-surgery).
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 3 Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy versus no surgery) in children
Outcome: 1 Episodes of sore throat of any severity (not including as one episode the period post-surgery)
Study or subgroup Surgery No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Adenotonsillectomy
Paradise 2002a 46 2.96 (1.39) 27 2.78 (1.66) 17.5 % 0.18 [ -0.56, 0.92 ]
Paradise 2002b 59 2.9 (1.37) 67 3.6 (1.87) 22.1 % -0.70 [ -1.27, -0.13 ]
van Staaij 2004 111 2.74 (1.76) 107 3.27 (2.42) 22.2 % -0.53 [ -1.09, 0.03 ]
Subtotal (95% CI) 216 201 61.8 % -0.40 [ -0.88, 0.07 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 3.57, df = 2 (P = 0.17); I2 =44%
Test for overall effect: Z = 1.66 (P = 0.098)
2 Tonsillectomy
Paradise 2002a 47 2.96 (1.1449) 27 2.78 (1.66) 18.4 % 0.18 [ -0.53, 0.89 ]
Subtotal (95% CI) 47 27 18.4 % 0.18 [ -0.53, 0.89 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
3 Mixed
Lock 2010 119 6 (5.16) 112 7.7 (5.88) 7.5 % -1.70 [ -3.13, -0.27 ]
Paradise 1984 38 2.24 (1.62) 35 3.09 (2.64) 12.3 % -0.85 [ -1.87, 0.17 ]
Subtotal (95% CI) 157 147 19.8 % -1.13 [ -1.96, -0.31 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.90, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 2.69 (P = 0.0072)
Total (95% CI) 420 375 100.0 % -0.44 [ -0.88, 0.00 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 10.12, df = 5 (P = 0.07); I2 =51%
Test for overall effect: Z = 1.95 (P = 0.051)
Test for subgroup differences: Chi2 = 5.61, df = 2 (P = 0.06), I2 =64%
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Analysis 3.2. Comparison 3 Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy
versus no surgery) in children, Outcome 2 Episodes of moderate/severe sore throat (not including as one
episode the period post-surgery).
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 3 Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy versus no surgery) in children
Outcome: 2 Episodes of moderate/severe sore throat (not including as one episode the period post-surgery)
Study or subgroup Surgery No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adenotonsillectomy
Paradise 2002a 47 1.17 (0.3406) 54 0.24 (0.51) 53.3 % 0.93 [ 0.76, 1.10 ]
Paradise 2002b 59 1.15 (0.42) 67 0.43 (0.67) 40.1 % 0.72 [ 0.53, 0.91 ]
van Staaij 2004 111 1.69 (0.91) 107 0.86 (2.34) 6.6 % 0.83 [ 0.36, 1.30 ]
Subtotal (95% CI) 217 228 100.0 % 0.84 [ 0.72, 0.96 ]
Heterogeneity: Chi2 = 2.60, df = 2 (P = 0.27); I2 =23%
Test for overall effect: Z = 13.47 (P < 0.00001)
2 Tonsillectomy
Paradise 2002a (1) 46 1.09 (0.2357) 27 0.24 (0.51) 100.0 % 0.85 [ 0.65, 1.05 ]
Subtotal (95% CI) 46 27 100.0 % 0.85 [ 0.65, 1.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.16 (P < 0.00001)
3 Mixed
Paradise 1984 38 0.08 (0.27) 35 1.17 (1.42) 50.0 % -1.09 [ -1.57, -0.61 ]
Paradise 1984 38 1.08 (0.27) 35 1.17 (1.42) 50.0 % -0.09 [ -0.57, 0.39 ]
Subtotal (95% CI) 76 70 100.0 % -0.59 [ -0.93, -0.25 ]
Heterogeneity: Chi2 = 8.40, df = 1 (P = 0.004); I2 =88%
Test for overall effect: Z = 3.42 (P = 0.00063)
Test for subgroup differences: Chi2 = 62.87, df = 2 (P = 0.00), I2 =97%
-4 -2 0 2 4
Favours surgery Favours no surgery
(1) The
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Analysis 3.3. Comparison 3 Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy
versus no surgery) in children, Outcome 3 Sore throat days (including those immediately post-surgery).
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 3 Subgroup analysis: by type of surgery (tonsillectomy or adenotonsillectomy versus no surgery) in children
Outcome: 3 Sore throat days (including those immediately post-surgery)
Study or subgroup Surgery No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adenotonsillectomy
Paradise 2002a 95 19.5 (14.5) 27 25 (21) 11.8 % -5.50 [ -13.94, 2.94 ]
Paradise 2002b 60 23 (20) 68 24 (17) 20.0 % -1.00 [ -7.48, 5.48 ]
van Staaij 2004 111 12.68 (9.5) 107 18.92 (24.59) 33.7 % -6.24 [ -11.22, -1.26 ]
Subtotal (95% CI) 266 202 65.4 % -4.51 [ -8.09, -0.93 ]
Heterogeneity: Chi2 = 1.64, df = 2 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 2.47 (P = 0.014)
2 Tonsillectomy
Paradise 2002a 95 19.5 (14.5) 27 25 (21) 11.8 % -5.50 [ -13.94, 2.94 ]
Subtotal (95% CI) 95 27 11.8 % -5.50 [ -13.94, 2.94 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.28 (P = 0.20)
3 Mixed
Lock 2010 110 31 (29.25) 107 49.1 (54.62) 6.1 % -18.10 [ -29.80, -6.40 ]
Paradise 1984 31 16.3 (14.3) 33 18.9 (14.6) 16.7 % -2.60 [ -9.68, 4.48 ]
Subtotal (95% CI) 141 140 22.8 % -6.75 [ -12.81, -0.69 ]
Heterogeneity: Chi2 = 4.93, df = 1 (P = 0.03); I2 =80%
Test for overall effect: Z = 2.18 (P = 0.029)
Total (95% CI) 502 369 100.0 % -5.14 [ -8.03, -2.24 ]
Heterogeneity: Chi2 = 6.98, df = 5 (P = 0.22); I2 =28%
Test for overall effect: Z = 3.48 (P = 0.00050)
Test for subgroup differences: Chi2 = 0.40, df = 2 (P = 0.82), I2 =0.0%
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Analysis 4.1. Comparison 4 Sensitivity analysis: tonsillectomy or adenotonsillectomy versus no surgery in
children - removing Lock 2010, Outcome 1 Episodes of sore throat of any severity (including as one episode the
period post-surgery) at 12 months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 4 Sensitivity analysis: tonsillectomy or adenotonsillectomy versus no surgery in children - removing Lock 2010
Outcome: 1 Episodes of sore throat of any severity (including as one episode the period post-surgery) at 12 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Paediatric patients - severely affected patients
Paradise 1984 38 2.24 (1.62) 35 3.09 (2.64) 13.9 % -0.85 [ -1.87, 0.17 ]
Subtotal (95% CI) 38 35 13.9 % -0.85 [ -1.87, 0.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
2 Paediatric patients - moderately affected patients
Paradise 2002a 93 2.91 (1.39) 54 2.78 (1.66) 30.0 % 0.13 [ -0.40, 0.66 ]
Paradise 2002b 59 2.9 (1.37) 67 3.6 (1.87) 28.0 % -0.70 [ -1.27, -0.13 ]
van Staaij 2004 111 2.74 (1.76) 107 3.27 (2.42) 28.2 % -0.53 [ -1.09, 0.03 ]
Subtotal (95% CI) 263 228 86.1 % -0.36 [ -0.86, 0.15 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 5.06, df = 2 (P = 0.08); I2 =60%
Test for overall effect: Z = 1.38 (P = 0.17)
Total (95% CI) 301 263 100.0 % -0.42 [ -0.87, 0.02 ]
Heterogeneity: Tau2 = 0.10; Chi2 = 5.94, df = 3 (P = 0.11); I2 =49%
Test for overall effect: Z = 1.88 (P = 0.060)
Test for subgroup differences: Chi2 = 0.73, df = 1 (P = 0.39), I2 =0.0%
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Analysis 4.2. Comparison 4 Sensitivity analysis: tonsillectomy or adenotonsillectomy versus no surgery in
children - removing Lock 2010, Outcome 2 Sore throat days (including those immediately post-surgery) at 12
months.
Review: Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis
Comparison: 4 Sensitivity analysis: tonsillectomy or adenotonsillectomy versus no surgery in children - removing Lock 2010
Outcome: 2 Sore throat days (including those immediately post-surgery) at 12 months
Study or subgroup Tonsil/adenotonsilectomy No surgery
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Paediatric patients - severely affected patients
Paradise 1984 31 16.3 (14.3) 33 18.9 (14.6) 18.3 % -2.60 [ -9.68, 4.48 ]
Subtotal (95% CI) 31 33 18.3 % -2.60 [ -9.68, 4.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
2 Paediatric patients - moderately affected patients
Paradise 2002a 95 19.5 (14.5) 54 25 (21) 23.0 % -5.50 [ -11.81, 0.81 ]
Paradise 2002b 60 23 (20) 68 24 (17) 21.8 % -1.00 [ -7.48, 5.48 ]
van Staaij 2004 111 12.68 (9.5) 107 18.92 (24.59) 36.9 % -6.24 [ -11.22, -1.26 ]
Subtotal (95% CI) 266 229 81.7 % -4.63 [ -7.98, -1.28 ]
Heterogeneity: Chi2 = 1.68, df = 2 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 2.71 (P = 0.0067)
Total (95% CI) 297 262 100.0 % -4.26 [ -7.29, -1.23 ]
Heterogeneity: Chi2 = 1.94, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 2.76 (P = 0.0058)
Test for subgroup differences: Chi2 = 0.26, df = 1 (P = 0.61), I2 =0.0%
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A D D I T I O N A L T A B L E S
Table 1. Complications from tonsillectomy/adenotonsillectomy
Study Type of complication Number of patients with complications
Paediatric patients
Lock 2010 Not reported (participants asked to record in a diary whether a list of symptoms - sore ear,
difficulty swallowing, nausea and vomiting, aches and pain etc. - was present)
Paradise 2002a and Paradise 2002b Total complication rates reported 16/203 (7.9%) reported
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Table 1. Complications from tonsillectomy/adenotonsillectomy (Continued)
Haemorrhage, intraoperative 3/203 (1.5%)
Haemorrhage, 2 days to 2 weeks post-surgery 7/203 (3.4%)
Anaesthetic induction trismus and ’possible’
incipient malignant hyperthermia
1/203 (0.5%)
Postoperative throat pain (days) Mean 6.3 (range 0 to 21 days)
Paradise 1984 Haemorrhage - “before discharge” 2/95 (2%)
Haemorrhage - “after discharge” 2/95 (2%)
van Staaij 2004 Total complication rates reported 12/145 (6%)
Primary haemorrhage 7/145 (4.8%)
Postoperative nausea 5/145 (3.4%)
Adults
Alho 2007 “Mild” secondary bleeding 2/36 (6%)
Postoperative throat pain (days) Mean 13 (SD 4)
Koskenkorva 2013 Readmission into hospital due to secondary
bleeding
2/46 (4.3%)
Readmission into hospital due to severe pain 1/46 (2.1%)
SD: standard deviation
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A P P E N D I C E S
Appendix 1. Revised search strategies used since January 2011
CENTRAL PubMed EMBASE (Ovid)
#1 MeSH descriptor Tonsillectomy ex-
plode all trees
#2 MeSH descriptor Palatine Tonsil ex-
plode all trees with qualifier: SU
#3 tonsillectom*:ti OR tonsilectom*:ti OR
adenotonsillectom*:ti OR adeno-tonsillec-
tom*:ti
#4 (tonsil*:ti OR adenotonsil*:ti) AND
(surg*:ti OR laser*:ti OR extract*:ti OR re-
sect*:ti OR excis*:ti OR operat*:ti OR dis-
sect*:tiOR remov*:tiOR coblat:ti*OR ab-
lat*:ti)
#5 (#1 OR #2 OR #3 OR #4)
#1 “Tonsillectomy” [Mesh] OR tonsillec-
tom* [ti] OR tonsilectom* [ti] OR adeno-
tonsillectom* [ti] OR adeno-tonsillectom*
[ti]
#2 “Palatine Tonsil/surgery”[Mesh]
#3 (Tonsil* [ti]OR adenotonsil* [ti]) AND
(SURG* [ti] OR OPERAT* [ti] OR EX-
CIS* [ti] OR EXTRACT* [ti] OR RE-
MOV* [ti] OR DISSECT* [ti] OR AB-
LAT* [ti] OR COBLAT* [ti] OR LASER*
[ti])
#4 #1 OR #2 OR #3
1 exp *tonsillectomy/
2 exp tonsil/su [Surgery]
3 (tonsillectom* or tonsilectom* or adeno-
tonsillectom* or adeno-tonsillectom*).ti.
4 ((Tonsil* or adenotonsil*) and (SURG*
or OPERAT* or EXCIS* or EXTRACT*
or REMOV* or DISSECT* or ABLAT* or
COBLAT* or LASER*)).ti.
5 1 or 2 or 3 or 4
CINAHL (EBSCO) Web of Science (Web of Knowledge) ICTRP
S1 (MH “Tonsillectomy”)
S2 TI tonsillectom* OR tonsilectom* OR
adenotonsillectom* OR adeno-tonsillec-
tom*
S3 TI (tonsil* OR adenotonsil*) AND
(surg* OR laser* OR extract* OR resect*
OR excis* OR operat* OR dissect* OR re-
mov* OR coblat* OR ablat*)
S4 S1 or S2 or S3
#1 TI=(tonsillectom* or tonsilectom*
or adenotonsillectom* or adeno-tonsillec-
tom*)
#2 TI=((Tonsil* or adenotonsil*) and
(SURG* or OPERAT* or EXCIS* or EX-
TRACT* or REMOV* or DISSECT* or
ABLAT* or COBLAT* or LASER*))
#3 #1 OR #2
tonsillectom*OR tonsilectom*OR adeno-
tonsillectom* OR adeno-tonsillectom*
Appendix 2. Search strategies used prior to January 2011
CENTRAL MEDLINE EMBASE
#1 TONSILLECTOMY single term
(MeSH)
#2 TONSIL [su] single term (MeSH)
#3TONSILLECTOM*ORTONSILEC-
TOM*
#4 ADENOTONSILLECTOM* OR
ADENOTONSILECTOM*
#5 #1 OR #2 OR #3 OR #4
#6 TONSILLITIS explode all trees
(MeSH)
1. TONSILLECTOMY.DE.
2. TONSIL-SU.DE.
3. (TONSILLECTOM$3 OR TON-
SILECTOM3).TI,AB.
4. (ADENOTONSILLECTOM$3 OR
ADENOTONSILECTOM$3).TI,AB.
5. 1 OR 2 OR 3 OR 4
6. TONSILLITIS#.DE.
7. TONSIL.DE.
8. (TONSIL$5 OR ADENOTONSIL$5)
1. TONSILLECTOMY#.DE.
2. TONSIL-DISEASE-SU#.DE.
3. (TONSILLECTOM$3 OR TON-
SILECTOM$3).TI,AB.
4. (ADENOTONSILLECTOM$3 OR
ADENOTONSILECTOM$3).TI,AB.
5. 1 OR 2 OR 3 OR 4
6. TONSILLITIS#.DE.
7. TONSIL.DE.
8. (TONSIL$5 OR ADENOTONSIL$5)
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(Continued)
#7 TONSIL single term (MeSH)
#8 TONSIL* OR ADENOTONSIL*
#9 #6 OR #7 OR #8
#10 SURGERY single term (MeSH)
#11 SURGICAL PROCEDURES ELEC-
TIVE single term (MeSH)
#12 OTORHINOLARYNGOLOGIC
SURGICAL PROCEDURES single term
(MeSH)
#13 OTOLARYNGOLOGY single term
(MeSH)
#14 SURG* OR OPERAT* OR EXCIS*
OR EXTRACT* OR REMOV* OR DIS-
SECT* OR ABLAT* OR COBLAT* OR
LASER*
#15 #10 OR #11 OR #12 OR #13 OR #
14
#16 #9 AND #15
#17 #5 OR #16
.TI,AB.
9. 6 OR 7 OR 8
10. SURGERY.DE.
11. SURGICAL-PROCEDURES-ELEC-
TIVE.DE.
12. OTORHINOLARYNGOLOGIC-
SURGICAL-PROCEDURES.DE.
13. OTOLARYNGOLOGY.DE.
14. (SURG$6 OR OPERAT$4 OR
EXCIS$4 OR EXTRACT$4 OR RE-
MOV$3 OR DISSECT$3 OR ABLAT$3
OR COBLAT$3 OR LASER$3).TI,AB.
15. 10 OR 11 OR 12 OR 13 OR 14
16. 9 AND 15
17. 5 OR 16
.TI,AB.
9. 6 OR 7 OR 8
10. SURGERY.DE.
11. SURGICAL-TECHNIQUE#.DE.
12. THROAT-SURGERY.DE.
13. EAR-NOSE-THROAT-SURGERY.
DE.
14. (SURG$6 OR OPERAT$4 OR EX-
CIS$4 OR EXTRACT$4 ORREMOV$3
OR DISSECT$3 OR ABLAT$3 OR
COBLAT$3 OR LASER$3).TI,AB.
15. 10 OR 11 OR 12 OR 13 OR 14
16. 9 AND 15
17. 5 OR 16
Appendix 3. Individual results of included studies
Study 1: Paradise 1984
The results of the Paradise 1984 trial are based on surgical intervention in 43 severely affected children compared to 48 control subjects.
Of those having surgery, 27 underwent tonsillectomy alone and 16 adenotonsillectomy; the results for the two procedures are pooled
and inseparable.
A: Episodes of sore throat of any severity
For the mean number of episodes of sore throats of any severity within 12 months the results are:
Adeno-/tonsillectomy group (n = 38) 1.2 episodes (SD 1.62)
Control group (n = 35) 3.1 episodes (SD 2.64)
However, we had to assume that the data had not included the episode post-surgery and, therefore, the number of episodes of sore
throat in the surgery group should be 2.2 episodes (SD 1.62).
B: Episodes of moderate/severe sore throat
The numbers of moderate or severe sore throats in the first year of the trial were as follows:
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Adeno-/tonsillectomy group (n = 38) 0.1 episodes (SD 0.27)
Control group (n = 35) 1.2 episodes (SD 1.42)
We must assume that the data for the surgical groups cannot include the immediate postoperative period as one episode of sore throat
(because if they did, the mean in the surgical group would have to be > 1). Therefore, the number of episodes of moderate to severe
sore throat should be 1.1 (SD 0.27) in the surgery group.
C: Sore throat days (including those immediately following surgery)
Data on the number of sore throat days in the surgical and control groups are only available for 31 and 33 children respectively (72%
and 69% of those enrolled) (see Paradise 1984, Table 5). Here sore throat days immediately after surgery are included and “the number
of days for each subject for each follow-up year was standardised on the basis of 365 days”. Data on the mean number of sore throat
days are as follows:
Adeno-/tonsillectomy group (n = 31) 16.3 days (SD 14.3)
Control group (n = 33) 18.9 days (SD 14.6)
The number of days with sore throat postoperatively varies considerably. In the Paradise 1984 trial a mean figure of 4.9 days is reported.
In the later studies there is a mean of 6.3 days with a wide range from 0 to 21 days (Paradise 2002a; Paradise 2002b). Furthermore, it is
interesting to note that despite the fact that the trial included only children who were severely affected by throat infections, following
enrolment in the trial many of those in the control (non-operated) group had few episodes of infection and these few were usually
mild. Of the 48 children in the original control group, seven (15%) had elected to have surgery before the end of the first year and
were excluded from analysis. Another six children were excluded because of loss to follow-up (n = 4) or not completing the whole 12-
month period (n = 2). Of the 35 remaining children, however, 26 (74% of that group; 54% of the whole control group) had either a
single episode of moderate or severe sore throat or none at all.
Adverse events associated with surgery
Of the 95 children treated with surgery (children of the randomised and non-randomised studies combined), 13 (14%) had surgery-
related complications and six of them (46% of the children that suffered from surgery-related complications; 6% of the children treated
with surgery) required one or more extra days in the hospital. The primary and secondary haemorrhage rates were both 2%, of which
none required transfusion.
Study 2: Paradise 2002a
In the Paradise 2002a; Paradise 2002b trials, the authors present their results in a slightly different way. Data are presented for the
number of episodes in the first 12 months (Paradise 2002a; Paradise 2002b, Table 2). However, the mean number of episodes and the
range is given, along with the 95% confidence interval for the mean. For the purposes of this review, the standard deviation of the
mean has had to be imputed, by dividing the confidence interval by four and multiplying by the
√
(N-1), where N is the number of
subjects in the relevant group.
The results of the Paradise 2002a trial are based on surgical intervention in 117 children less severely affected than those included
in Paradise 1984 (tonsillectomy: 58 children; adenotonsillectomy: 59 children) compared to 60 control subjects. Results for the two
procedures are presented separately. The results are presented as the mean number of episodes and sore throat days with accompanying
standard deviations.
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A: Episodes of sore throat of any severity
For the mean number of episodes of “all [degrees of sore throat] combined” in the first year results are (*SD imputed as described):
Tonsillectomy group (n = 47) 2.0 episodes (95% CI 1.58 to 2.40; SD* 1.39)
Adenotonsillectomy group (n = 46) 1.9 episodes (95% CI 1.51 to 2.34; SD* 1.39)
Combined: tonsillectomy and adenotonsillectomy (n = 93) 1.9 episodes (SD 1.39)
Control group (n = 54) 2.8 episodes (95% CI 2.35 to 3.26; SD* 1.66)
However, we noted that the number of episodes was unlikely to include the episode of pain due to the surgery. Therefore, to include
the episode of pain due to surgery, the analysis considered the episodes of sore throat in the tonsillectomy group as 3.0 episodes (SD*
1.39) in the tonsillectomy group and 2.9 episodes (SD* 1.39) in the adenotonsillectomy group.
B: Episodes of moderate/severe sore throat
For the mean number of episodes of moderate or severe sore throat in the first year results are (*SD imputed as described):
Tonsillectomy group (n = 47) 0.2 episodes (95% CI 0.07 to 0.34; SD* 0.46)
Adenotonsillectomy group (n = 46) 0.1 episodes (95% CI 0.02 to 0.23; SD* 0.35)
Combined: tonsillectomy and adenotonsillectomy (n = 93) 0.1 episodes (SD 0.41)
Control group (n = 54) 0.2 episodes (95% CI 0.13 to 0.41; SD* 0.51)
The data for the surgical groups cannot include the immediate postoperative period as one episode of sore throat (see above). The
clinical interpretation therefore must be that the ’benefit’ of avoiding 0.9 episodes of any sore throat is offset by the episode of sore
throat attributable to the surgery, whilst there was no benefit in terms of a reduction in the number of episodes of moderate/severe sore
throat after the immediate postoperative period, despite having experienced the postoperative episode of pain that naturally follows
the surgery. To include the episode of pain due to surgery in the analysis, the number of episodes of moderate or severe sore throat was
considered as 1.2 (SD 0.46) in the tonsillectomy group and 1.1 (SD 0.35) in the adenotonsillectomy group.
C: Sore throat days (including those immediately following surgery)
Data are available on the number of sore throat days in the first 12 months. These are presented as the mean number of sore throat
days and standard deviations. As in the Paradise 1984 trial, the data are “limited to subjects with at least 270 days of reportage in a
follow-up year”, the sore throat days immediately after surgery are included and “the number of days for each subject for each follow-
up year was standardised on the basis of 365 days”. Data are available for slightly more children:
69Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Tonsillectomy group (n = 48) 20 days (SD 14)
Adenotonsillectomy group (n = 47) 19 days (SD 15)
Combined: tonsillectomy and adenotonsillectomy (n = 95) 20 days (SD 14.5)
Control group (n = 54) 25 days (SD 21)
Adverse events associated with surgery
Of the 203 children who underwent surgery (in the entire study, Paradise 2002a and Paradise 2002b combined) 16 (7.9%) had intra-
or postoperative complications. The primary and secondary haemorrhage rates were 1.5% and 3.4%, respectively.
Study 3: Paradise 2002b
The results of the Paradise 2002b trial are based on surgical intervention (adenotonsillectomy) in 73 less severely affected children than
those included in Paradise 1984 compared to 78 control subjects. The results are presented in an identical way to Paradise 2002a, as
the mean number of episodes and sore throat days with accompanying standard deviations and by intention-to-treat.
A: Episodes of sore throat of any severity
For the mean number of episodes of “all [degrees of sore throat] combined” in the first year results are (* SD imputed as described):
Adenotonsillectomy group (n = 59) 1.9 episodes (95% CI 1.56 to 2.28; SD* 1.37)
Control group (n = 67) 3.6 episodes (95% CI 3.16 to 4.08; SD* 1.87)
As the data were unlikely to account for the episode due to surgery, we added one episode to the surgery group. The mean number of
episodes should be 2.9 SD 1.37.
B: Episodes of moderate/severe sore throat
For the mean number of episodes of moderate or severe sore throat in the first year the results are (*SD imputed as described):
Adenotonsillectomy group (n = 59) 0.2 episodes (95% CI 0.07 to 0.29; SD* 0.42)
Control group (n = 67) 0.4 episodes (95% CI 0.29 to 0.62; SD* 0.67)
The data for the surgical groups cannot include the immediate postoperative period as one episode of sore throat (see above). Therefore,
for the purpose of data analysis, we added one episode to the surgery group; the mean number of episodes should be 1.2 (SD 0.42).
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C: Sore throat days (including those immediately following surgery)
Data are available on the number of sore throat days in the first 12 months. These are presented as the mean number of sore throat
days and standard deviations. As in the Paradise 1984 trial, data are “limited to subjects with at least 270 days of reportage in a follow-
up year”, the sore throat days immediately after surgery are included and “the number of days for each subject for each follow-up year
was standardised on the basis of 365 days”. Data are available for slightly more children:
Adenotonsillectomy group (n = 60) 23 days (SD 20)
Control group (n = 68) 24 days (SD 17)
The difference between the adenotonsillectomy group and the control group is not statistically significant: -1 day (95% CI -7.48 to
5.48), and the issues of timing and predictability apply again.
Adverse events associated with surgery
See above.
Study 4: van Staaij 2004
The primary outcome measure in this trial was the incidence and duration of fever (temperature of 38.0 °C or higher) for at least one
day. Secondary outcome measures included throat infections (fever plus sore throat or pain or difficulty swallowing) and sore throats
(sore throat or pain or difficulty swallowing with or without fever). Data relating to outcomes at 12 months, comparable to those in
the Paradise studies (Paradise 1984; Paradise 2002a; Paradise 2002b), are not presented in the paper reporting the results of this trial
but have been obtained from the trialists.
The results of the van Staaij 2004 trial are based on surgical intervention (adenotonsillectomy) in 151 children with mild to moderate
symptoms compared to 149 control (watchful waiting) subjects. The results are presented as the mean number of episodes and sore
throat days with accompanying standard deviations and according the group randomised. (Results from the authors).
A: Episodes of sore throat of any severity
The number of episodes of sore throat in the first year of the trial, including as one of these episodes the sore throat immediately
following surgery (unlike the Paradise studies), were as follows:
Adenotonsillectomy group (n = 111) 2.7 episodes (SD 1.76)
Control group (n = 107) 3.3 episodes (SD 2.42)
B: Episodes of moderate/severe sore throat
The number of episodes of throat infection in the first year of the trial, were as follows:
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Adenotonsillectomy group (n = 111) 0.7 episodes (SD 0.91)
Control group (n = 107) 0.9 episodes (SD 1.12)
In this case, the episode of sore throat following surgery cannot have routinely been included as an episode of ’throat infection’ (see
above). The difference between the adenotonsillectomy group and the control group in the number of episodes of moderate/severe sore
throat is not statistically significant: -0.2 episodes (95% CI -0.64 to 0.30).
To allow a similar comparison with other data, the episode due to surgery should be included. Therefore, the number of episodes of
moderate or severe pain should be 1.7 (SD 0.91) in the adenotonsillectomy group.
C: Sore throat days (including those immediately following surgery)
The number of sore throat days (also including sore throat days immediately following surgery) in the first year of the trial was:
Adenotonsillectomy group (n = 111) 12.7 days (SD 9.5)
Control group (n = 107) 18.9 days (SD 24.59)
The difference between the adenotonsillectomy group and the control treatment group is statistically significant: -6.2 days (95% CI -
11.22 to -1.26). The issues of timing and predictability apply equally here.
Van Staaij 2004 - year two data
The study has relatively low loss to follow-up overall. However, not all patients completed two years of follow-up as the study had to
stop at a predetermined time point (February 2003). Overall, losses to follow-up were relatively low for this study: 88% (133/151)
and 83% (124/149) of the adenotonsillectomy and control groups respectively. However, the study was designed to complete at a
predetermined time point (February 2003) and, therefore, not all patients could complete up to 2 years of follow-up.
The authors confirmed that whilst there were 300 randomised participants, 24-month data were only potentially available for a group
of 166 who had been in the trial long enough to complete 24 months follow-up. In fact, data were only available for 80 of these 166
participants. Data on the occurrence of sore throats in the second year (months 13 to 24) were not available.
The published data (referring to rates per year) record the incidence of symptoms at a median follow-up interval of 22 months. These
are:
A: Episodes of sore throat of any severity
Adenotonsillectomy group 2.25 episodes per year 4.5 episodes over 2 years
Control group 2.85 episodes per year 5.7 episodes over 2 years
B: Episodes of moderate/severe sore throat
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Adenotonsillectomy group 0.56 episodes per year 1.12 episodes over 2 years
Control group 0.77 episodes per year 1.54 episodes over 2 years
C: Sore throat days (including those immediately following surgery)
Adenotonsillectomy group 9.81 days per year 19.62 days over 2 years
Control group 15.71 days per year 31.42 days over 2 years
Each of these published comparisons reveal statistically significant differences in:
(A) episodes of any sore throat per year of -0.60 episodes (95% CI -0.90 to -0.30);
(B) episodes of moderate/severe sore throat per year of -0.21 (95% CI -0.36 to -0.06);
(C) sore throat days of -5.91 (95% CI -6.57 to -5.24) in favour of the adenotonsillectomy group.
Again, note that some of these data include sore throats in the immediate postoperative period.
Adverse events associated with surgery
Of the 195 children who underwent surgery (145 in the adenotonsillectomy group and 50 in the watchful waiting group) 12 (6%)
had complications related to surgery. The primary haemorrhage rate was 4% (secondary rate not given).
Study 5: Lock 2010
The primary outcome measure in this trial was the reported number of episodes of sore throat. Secondary outcomes included reported
number of episodes of sore throat that invoked a GP consultation and number of days with sore throat.
The results of the Lock 2010 trial are based on surgical intervention (tonsillectomy alone or adenotonsillectomy) in 131 children with
recurrent acute sore throat compared to 137 control subjects. In the control group, 26% (36/137) elected to undergo surgery during
follow-up, whereas 8% (11/131) children allocated to adeno-/tonsillectomy did not receive surgery. The results are presented as the
mean number of episodes and sore throat days with accompanying standard deviations and by intention-to-treat.
A: Episodes of sore throat of any severity
The number of episodes of sore throat in the first year of the trial, including as one of these episodes the sore throat immediately
following surgery (unlike the Paradise studies), was as follows:
Adeno-/tonsillectomy group (n = 119) 6 episodes (SD 5.16)
Control group (n = 112) 7.7 episodes (SD 5.88)
B: Episodes of sore throat that invoked a GP consultation
The number of episodes of sore throat that evoked a GP consultation in the first year of the trial, not including the sore throat
immediately following surgery, was as follows:
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Adeno-/tonsillectomy group (n = 92) 1.9 episodes (SD 2.84)
Control group (n = 93) 2.4 episodes (SD 2.35)
The difference between the adenotonsillectomy group and the control treatment group in the number of episodes of sore throat that
invoked a GP consultation is not statistically significant: -0.5 episodes (95% CI -1.2 to 0.3).
C: Sore throat days (including those immediately following surgery)
Data are reported on the number of days with sore throat including postoperative throat pain in the adeno-/tonsillectomy group:
Adeno-/tonsillectomy group (n = 110) 31.0 days (SD 29.25)
Control group (n = 107) 49.1 days (SD 54.62)
The difference between the adeno-/tonsillectomy group and the control treatment group is statistically significant: -18.1 days (95% CI
-13.85 to -3.75).
Adverse events associated with surgery
Although surgical and anaesthetic morbidity was defined as an important secondary clinical outcome, no information on this endpoint
is provided in the Lock 2010 publication.
Study 6: Alho 2007
The primary outcome measure in this trial was the proportion of patients with an acute episode of group A streptococcal pharyngitis
during a 90-day follow-up period. Secondary outcomes included patient-recorded episodes (defined as at least two consecutive days)
of sore throat and ’days with symptoms’. The secondary outcomes are reported as means and standard deviations “at the end of whole
follow-up”. The data reported relate to a “mean length of follow-up 164 days (SD 63) in control group and 170 days (SD 12) in
tonsillectomy group”.
The results of the Alho 2007 trial are based on tonsillectomy in 36 adults with recurrent “group A streptococcal pharyngitis” compared
to 34 control subjects. In the control group, 5% (2/34) had elected to undergo surgery during follow-up, whereas all adults allocated
to tonsillectomy received surgery. The results are presented as the mean number of episodes and sore throat days with accompanying
standard deviations and by intention-to-treat.
A: Episodes of sore throat
For ’all episodes of pharyngitis’ the reported data are:
Tonsillectomy group (n = 36) 0.6 episodes (SD 0.9) over follow-up period (mean 170 days)
Control group (n = 34) 2.1 episodes (SD 2.3) over follow-up period (mean 164 days)
The difference is reported as significant (P value = 0.001; Mann-Whitney U test). The data for the surgical group cannot include the
immediate postoperative period as one episode of sore throat because the mean is less than one. The difference of 1.5 episodes (95%
CI -2.33 to -0.67), occurring in the first five to six months after surgery, must therefore again be considered in the context of the one
episode of postoperative pain.
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B: Sore throat days (not including those immediately following surgery)
Data are reported on the number of days with sore throat “not including postoperative throat pain in tonsillectomy group”:
Tonsillectomy group (n = 36) 3.2 days* (SD 5.3) over follow-up period (mean 170 days)
Control group (n = 34) 12.1 days (SD 14.1) over follow-up period (mean 164 days)
*not including the 13 days due to surgery
The difference is reported as significant (P value = 0.002; Mann-Whitney U test). In this study, the gain of 8.9 sore throat-free days
(95% CI -13.95 to -3.85), occurring in the first five to six months after surgery, was bought at the cost of the days of postoperative
pain. Patients in the tonsillectomy group had on average 13 days (SD 4) of throat pain during the immediate postoperative period.
Adverse events associated with surgery
There were no “serious adverse effects related to tonsillectomy” in any of the 70 adult participants. Two patients (6%) had secondary
haemorrhages.
Study 7: Koskenkorva 2013
The primary outcome measure in this trial was the proportion of patients who had a severe episode of pharyngitis within five months.
Secondary outcomes included patient-reported episodes (defined as at least two consecutive days) of sore throat, number of sore throat
days and number of days absent from school and work. The secondary outcomes are reported as means and standard deviations “at
the end of follow-up”. The data reported relate to a “mean length of follow-up 5.7 months in the control group and 6.2 months in
tonsillectomy group”.
The results of the Koskenkorva 2013 trial are based on surgical intervention (tonsillectomy) in 46 adults with recurrent pharyngitis of
any origin compared to 40 control subjects. In the control group, 8% (3/40) had elected to undergo surgery during follow-up, whereas
all adults allocated to tonsillectomy received surgery. The results are presented as the mean number of episodes and sore throat days
with accompanying standard deviations and by intention-to-treat.
A: Episodes of sore throat
For ’episodes of sore throat’ the reported data are:
Tonsillectomy group (n = 46) 1.5 episodes (SD 2.4) over follow-up period (mean 6.2 months)
Control group (n = 40) 7.4 episodes (SD 5.8) over follow-up period (mean 5.7 months)
The difference is reported as significant (P value < 0.01; Mann-Whitney U test). The data for the surgical group did not include the
immediate postoperative period. The difference of 5.9 episodes (95% CI -7.83 to -3.97), occurring in the first five to six months after
surgery, must therefore again be considered in the context of the one episode of postoperative pain.
B: Sore throat days (NOT including those immediately following surgery)
Data are reported on the number of days with sore throat “not including postoperative throat pain in tonsillectomy group”:
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Tonsillectomy group (n = 46) 5.1* days (SD 8.7) over follow-up period (mean 6.2 months)
Control group (n = 40) 40.2 days (SD 60.5) over follow-up period (mean 5.7 months)
*not including the 17 days due to surgery
The difference is reported as significant (P value < 0.01; Mann-Whitney U test). In this study, the gain of 35.1 sore throat-free days
(95% CI -54.02 to -16.18), occurring in the first five to six months after surgery, was bought at the cost of the days of postoperative
pain. Patients in the tonsillectomy group had on average 17 days (SD 6) of throat pain during the immediate postoperative period.
Absence from school or work
Data are reported on the number of days absent from school or work “not including the postoperative period in tonsillectomy group”:
Tonsillectomy group (n = 46) 3.3* days (SD 10.0) over follow-up period (mean 6.2 months)
Control group (n = 40) 6.6 days (SD 11.8) over follow-up period (mean 5.7 months)
*not including the 14 days absence due to surgery
The difference is reported as significant (P value = 0.02; Mann-Whitney U test). In this study, the gain of 3.3 days (95% CI -7.96 to
1.36), occurring in the first five to six months after surgery, was bought at the cost of the days absent from work or school immediately
after surgery. Patients in the tonsillectomy group had on average 14 days (SD 6) absence from school or work during the immediate
postoperative period.
Adverse events associated with surgery
Three patients (6%) were readmitted to the hospital; one patient (2%) because of severe throat pain and two (4%) because of mild
secondary bleeding at one and four days after the operation.
F E E D B A C K
Paradise 2000
Summary
Editor’s note: These comments relate to the original (1999) version of the review.
In a recent Cochrane review (Burton 1999) critiquing our randomized clinical trial of tonsillectomy in severely affected children
(Paradise 1984), Burton, Towler, and Glasziou concluded that “significant baseline differences (in the history of antecedent throat
infections and in parents’ socioeconomic status) between the surgical and non-surgical groups and the inclusion of children who also
underwent adenoidectomy prevent firm conclusions being drawn from the . . . trial.” However, the Burton review fails to take into
account a number of study features and findings that argue strongly against the importance of these factors as potential invalidators of
our trial results.
First, consider the large differences in key outcomes favoring surgical over control subjects: in the first follow-up year a 14-fold reduction
in throat infection episodes rated as moderate or severe (3 episodes in 38 surgical subjects vs 41 episodes in 35 control subjects), and in
the second follow-up year, a 6-fold reduction (5 episodes in 31 surgical subjects vs 30 episodes in 29 control subjects). Other outcome
differences were less dramatic but consistently in the same direction and also significant statistically.
Second, as we reported, tests for interaction albeit their limited power showed no significant differences in treatment outcomes that were
related to any of the three factors cited by Burton et al (i.e. history of antecedent episodes, socioeconomic status, and presence or absence
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of indications for adenoidectomy), nor were any of these factors related significantly to outcomes within the control group. Imbalances
in factors that are not prognostic cannot fairly be considered sources of bias. Moreover, as we also reported, within each identifiable
clinical and sociodemographic subgroup rates of throat infection were, without exception, lower for subjects treated surgically than for
controls.
Third, consider the differences in antecedent history, which in any case may have been more apparent than real. Eligibility for our
trial required a history of seven or more episodes of throat infection in the preceding year, five or more in each of the two preceding
years, or three or more in each of the three preceding years. Not stated in our report were the facts that a number of children met more
than one of these criteria and that such children were categorized as meeting the criterion involving the largest number of episodes.
As chance would have it, more children in the surgical group than in the control group (20/43 vs 11/48) met the criterion of seven or
more episodes in the preceding year. From this, Burton et al concluded that “the surgical group may therefore have included children
with more severe disease,” or “alternatively, these may have been children with less severe, but more short-lived disease.” Setting aside
for a moment that the analyses cited above argue against any prognostically important differences in disease severity, if the surgical
group did indeed include children with more severe disease, the resulting bias would have favored control subjects rather than surgical
subjects, in which case trial results would have understated, not overstated, the efficacy of surgery. Burton et al advance no rationale
for their contrary, counterintuitive speculation that such children might actually have had less severe disease, but even if that had been
the case the imbalance would hardly seem sufficient to account for the large differences in outcome.
Fourth, the difference in socioeconomic status referred to by Burton et al favored the control group rather than the surgical group.
Again setting aside that the analyses cited above argued against the possibility that the difference was important prognostically, any
resulting bias again might be expected to have favored control subjects, not surgical subjects.
In summary, to explain the large outcome differences we found favoring the surgical group on the basis of confounding would have
required extreme imbalances between the surgical and control groups in variables that were strongly prognostic. In fact, however, not
only were the variables of concern not apparently prognostic and their imbalances limited, but further, the expected effect of the
imbalances would have been to favour the control group.
Finally, with regard to the adenoidectomy issue, Burton et al suggest that “Some part--potentially the greatest part--of the effect of
’surgery’ could be due to removal of the adenoids.” On the contrary--and again apart from the analyses described above--the addition
of adenoidectomy in a minority of the surgically treated subjects could certainly not have accounted for the fact that moderate and
severe throat-infection episodes were also virtually eliminated in the majority of such subjects who underwent tonsillectomy only.
We stand by our conclusion that in these severely affected children, tonsillectomy was unequivocally efficacious in reducing the
occurrence of throat infection.
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Professor Paradise’s comments have been addressed in this updated (2009) version of the review.
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WH A T ’ S N E W
Date Event Description
3 November 2014 New citation required but conclusions have not
changed
The general conclusions and recommendations regard-
ing the effectiveness of adeno-/tonsillectomy versus
(initial) non-surgical treatment remain unchanged
We have reorganised the data-analysis, with the addi-
tion of newdata since the last publishedupdate (Burton
2009). The data are now analysed as adeno-/tonsillec-
tomy for adults and adeno-/tonsillectomy for children.
We carried out additional sensitivity analyses to test
whether any differences could be observed for adeno-
tonsillectomy versus tonsillectomy alone, and to assess
the impact of studies with high risk of attrition bias on
the outcomes
We have amended the analysis such that the data for
children counted the episode of surgery as one episode
of pain, and also counted the days of pain associated
with the surgical procedure. However, it was not possi-
ble to do so for the data for adults, where the number
of days of pain as a result of surgery were not included
in the results for days with pain. Therefore, the data
for adults still exclude the episode of pain and days of
pain associated with the surgical procedure
Two new review authors (Roderick Venekamp and Lee
Yee Chong) joined the team to update this review
30 June 2014 New search has been performed We updated the searches in June 2014.
Three new trials have been included in the 2014 up-
date (Koskenkorva 2013; Lock 2010; Stafford 1986).
The first trial determined the effectiveness of tonsillec-
tomy versus short courses of antibiotics for each episode
of tonsillitis in 40 adults (Stafford 1986), but was at
high risk of bias and did not provide any data suit-
able for analysis. The second trial determined the effec-
tiveness of adeno-/tonsillectomy versus (initial) stan-
dard non-surgical treatment in children aged between
4 and 15 years with recurrent sore throats (four or
more episodes of sore throat within each of two years
or six or more episodes of sore throat within one year)
and provided data on the mean number of ’any type
of sore throat’ and days with sore throat after one
year of follow-up (Lock 2010). The third trial de-
termined the short-term effectiveness of tonsillectomy
versus watchful waiting in patients aged 13 years and
older with recurrent pharyngitis of any origin (three
or more episodes of pharyngitis in the previous 12
months) and provided data on the mean number of
’any type of sore throat’, days with sore throat and days
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(Continued)
absent from school or work after five to six months
follow-up (Koskenkorva 2013). We also identified one
ongoing trial (NATTINA 2014).
H I S T O R Y
Date Event Description
11 November 2008 New citation required and conclusions have changed Review substantially updated following new searches
in April 2008
11 April 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
Martin Burton: protocol development, searching for trials, quality assessment of trials, data extraction, review development.
Paul Glasziou: protocol and review development.
Roderick Venekamp: conducting searches, identifying studies, extracting data and preparing the manuscript for the updated review in
2014.
Lee Yee Chong: conducting searches, identifying studies, extracting data and preparing the manuscript for the updated review in 2014.
All authors have reviewed and provided comments on the updated version of the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• None, Other.
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External sources
• None, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In this 2014 update, we have made a number of changes to the protocol to enhance clarity and to reflect important changes in
methodology, views on the importance of outcomes and reporting format since the protocol was first published in 1999.
These include:
• inclusion of ’Summary of findings’ tables;
• addition of further definitions of morbidity;
• including quality of life as a outcome to reflect the morbidity of the condition and the surgery;
• adding a line to clarify that the authors had an intention to analyse results from children and adults separately a priori;
• adding a sensitivity analysis by type of surgery (adenotonsillectomy or tonsillectomy).
N O T E S
The original protocol for this review was titled ’Tonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis’. The
title was changed to include adenotonsillectomy when the first version of the full review was published. This reflected a change of scope
which paralleled both day-to-day clinical practice and the interventions studied by the available studies. This is commented upon in
the text of the review. The most important difference between the current version of the review and the previous one, Burton 2009, is
the inclusion of three additional trials (Koskenkorva 2013; Lock 2010; Stafford 1986). The general conclusions and recommendations
regarding the effects of adeno-/tonsillectomy versus (initial) non-surgical treatment in children and adults with chronic/recurrent acute
tonsillitis on the number of any sore throat episodes, the number of moderate or severe sore throat episodes and the number of days
with sore throat remained unchanged.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Adenoidectomy; ∗Tonsillectomy; Acute Disease; Chronic Disease; Pharyngitis [diagnosis]; Randomized Controlled Trials as Topic;
Recurrence; Tonsillitis [surgery; ∗therapy]
MeSH check words
Adult; Child; Humans
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